Page last updated: 2024-12-05

plumbagin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Plumbagin is a naturally occurring naphthoquinone found in the roots of the plumbago plant. It has been shown to exhibit a wide range of biological activities including anti-inflammatory, antioxidant, anticancer, antimicrobial, and antiparasitic effects. Plumbagin's potential medicinal properties have been investigated in numerous studies. It is known to induce apoptosis in cancer cells through various mechanisms, including oxidative stress and the inhibition of key signaling pathways. Researchers are exploring plumbagin's therapeutic potential for treating a variety of diseases such as cancer, inflammation, and bacterial infections. However, its clinical use is limited due to its toxicity and its potential for side effects. Current research focuses on finding ways to improve its safety profile and enhance its therapeutic efficacy. Furthermore, ongoing research is investigating plumbagin's potential as a lead compound for the development of new drugs.'

plumbagin: a superoxide anion generator [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

plumbagin : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone in which the hydrogens at positions 2 and 5 are substituted by methyl and hydroxy groups, respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10205
CHEMBL ID295316
CHEBI ID8273
SCHEMBL ID34186
MeSH IDM0063553

Synonyms (79)

Synonym
BRD-K36137799-001-02-4
plumbagine
plumbaein
1, 5-hydroxy-2-methyl-
5-hydroxy-2-methyl-1,4-naphthalenedione
nsc-236613
wln: l66 bv evj c1 gq
NCI60_001904
2-methyljuglone
2-methyl-5-hydroxy-1,4-naphthoquinone
plumbagone
5-hydroxy-2-methylnaphthalene-1,4-dione
CHEBI:8273 ,
1,4-naphthalenedione, 5-hydroxy-2-methyl-
nsc 688284
brn 1870475
einecs 207-569-6
nsc 236613
ai3-38055
1,4-naphthoquinone, 5-hydroxy-2-methyl-
ccris 6671
ACON1_001611
nsc236613
nsc688284
5-hydroxy-2-methyl-1,4-naphthoquinone
5-hydroxy-2-methyl-naphthalene-1,4-dione
BSPBIO_002546
plumbagin
481-42-5
plumbagin from plumbago indica
nsc-688284
NCGC00094567-01
NCGC00094567-02
NCGC00094567-03
SPECTRUM1505129
NCGC00094567-04
NCGC00094567-05
inchi=1/c11h8o3/c1-6-5-9(13)10-7(11(6)14)3-2-4-8(10)12/h2-5,12h,1h
5- hydroxy,2-methyl-1,4-naphtoquinone
pcur-101
CHEMBL295316 ,
P1139
5-hydroxy-2-methyl-[1,4]naphthoquinone
pumbagin
bdbm50012070
NCGC00094567-06
ST069355
A827479
AKOS015969699
unii-yas4tbq4oq
4-08-00-02376 (beilstein handbook reference)
yas4tbq4oq ,
FT-0602795
S4777
rtk1
gtpl7003
5-hydroxy-2-methyl-1,4-dihydronaphthalene-1,4-dione
CCG-208410
CCG-208032
SCHEMBL34186
plumbagin [mi]
plumbagin [who-dd]
A1-00788
W-202844
mfcd00001682
DTXSID8075413
SR-05000002263-2
SR-05000002263-3
sr-05000002263
ophioxylin
plumbapin
Q2550553
BRD-K36137799-001-03-2
PS-11338
HMS3870L13
CS-0017042
HY-N1497
STL564479
BP-25404

Research Excerpts

Overview

Plumbagin (PLB) is a phytochemical being used for centuries in traditional medicines. Plumbagin is a naphthoquinone, isolated from the roots of medicinal plant Plumbago zeylanica. It is widely present in Lawsonia inermis L.

ExcerptReferenceRelevance
"Plumbagin (1) is a naphthoquinone constituent of plants that have been used in traditional systems of medicine since ancient times. "( Interventional effects of plumbagin on experimental ulcerative colitis in mice.
Davis, CD; Navalta, JW; Pile, JE; Sharma, NC, 2013
)
2.13
"Plumbagin proved to be a promising substance for the control of B. "( Toxic, cytotoxic and genotoxic effect of plumbagin in the developmental stages of Biomphalaria glabrata (Say, 1818-intermediate host) and cercaricidal activity against the infectious agent of schistosomiasis mansoni.
Coelho, LCBB; da Silva, AM; de Araújo, HDA; de Azevedo Albuquerque, MCP; de Lima Aires, A; De Melo, AMMA; Diniz, EGM; França, WWM; Pereira, DR; Silva, HAMF, 2022
)
2.43
"Plumbagin is a natural compound known to impede growth of cancerous cells. "( Plumbagin downregulates UHRF1, p-Akt, MMP-2 and suppresses survival, growth and migration of cervical cancer CaSki cells.
Capalash, N; Sidhu, H, 2023
)
3.8
"Plumbagin is an emerging anti-cancer compound."( Anti-ovarian cancer actions and pharmacological targets of plumbagin.
Chen, Y; Huang, S; Liang, K; Pan, X, 2023
)
1.87
"Plumbagin is a potent pharmaceutical because of its anti-microbial, anti-malarial, antifungal, anti-inflammatory, anti-carcinogenic, anti-fertility, anti-plasmodium, antioxidant, anti-diabetic, and other effects."( Approaches for in vitro propagation and production of plumbagin in Plumbago spp.
Das, T; Dey, A; Dhama, K; Gopalakrishnan, AV; Katoch, K; Majumder, M; Mane, AB; Pandey, DK, 2023
)
1.88
"Plumbagin (PLB) is a phytochemical being used for centuries in traditional medicines. "( Molecular pathways related to the control of proliferation and cell death in 786-O cells treated with plumbagin.
Baranoski, A; Biazi, BI; Coatti, GC; Corveloni, AC; Lepri, SR; Mancilla, IA; Mantovani, MS; Marques, LA; Zanetti, TA, 2019
)
2.17
"Plumbagin is a potent anti-tumour agent and has been shown to sensitize tumour cells to radiation-induced damage."( Modulation of Caspase-3 activity using a redox active vitamin K3 analogue, plumbagin, as a novel strategy for radioprotection.
Basu, B; Checker, R; Pal, D; Patwardhan, RS; Sandur, SK; Sharma, D, 2019
)
1.47
"Plumbagin is a naphthoquinone (5-hydroxy-2-methyl-1, 4-naphthoquinone), isolated from the roots of medicinal plant Plumbago zeylanica, and it is widely present in Lawsonia inermis L."( Elucidation of the effect of plumbagin on the metastatic potential of B16F10 murine melanoma cells via MAPK signalling pathway.
Alem, FZ; Bejaoui, M; Isoda, H; Rhourri-Frih, B; Villareal, MO, 2020
)
1.57
"Plumbagin is a major bioactive compound that occurs in the Plumbago indica and P."( Plumbagin protects the myocardial damage by modulating the cardiac biomarkers, antioxidants, and apoptosis signaling in the doxorubicin-induced cardiotoxicity in rats.
Ali Alharbi, S; Chinnathambi, A; Li, Z; Yin, F, 2020
)
2.72
"Plumbagin is a pharmacologically active naphthoquinone present in the Plumbago zeylanica L. "( Differential transcriptome and metabolome analysis of Plumbago zeylanica L. reveal putative genes involved in plumbagin biosynthesis.
Barvkar, VT; Pable, AA; Vasav, AP, 2020
)
2.21
"Plumbagin is a bioactive compound, which is mainly present in Plumbaginaceae family and has been explored for its anticancer activity."( Plumbagin: A Potential Anti-cancer Compound.
Roy, A, 2021
)
2.79
"Plumbagin (PLB) is a naphthoquinone endowed with potential medicinal properties, including anticancer activities. "( Plumbagin induces Ishikawa cell cycle arrest, autophagy, and apoptosis via the PI3K/Akt signaling pathway in endometrial cancer.
Ding, W; Kan, H; Liu, Y; Zhang, X, 2021
)
3.51
"Plumbagin is a plant-derived naphthoquinone that is widely used in traditional Asian medicine due to its anti-inflammatory and anti-microbial properties. "( Plumbagin, a Biomolecule with (Anti)Osteoclastic Properties.
Ashma, R; Ghumnani, S; Kubatzky, KF; Sultanli, S, 2021
)
3.51
"Plumbagin (PLB) is a plant small molecule naphthoquinone compound."( Plumbagin Inhibits Proliferation, Migration, and Invasion of Retinal Pigment Epithelial Cells Induced by FGF-2.
An, J; Hao, J; Liu, L; Ma, J; Wang, R; Zhang, H; Zhang, Y, 2021
)
2.79
"Plumbagin is a natural naphthoquinone constituent isolated from the roots of medicinal plant Plumbago zeylanica L., and has demonstrated anti-proliferative and anti-invasion activities in various cancer cells. "( Plumbagin suppresses the migration and invasion of glioma cells via downregulation of MMP-2/9 expression and inaction of PI3K/Akt signaling pathway in vitro.
Chen, G; Qin, J; Ren, Q; Xiao, B; Xiao, X; Yue, Y, 2017
)
3.34
"Plumbagin is a candidate drug for the treatment of prostate cancer. "( Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: A pre-clinical study.
Abedinpour, P; Baron, VT; Borgström, P; Chrastina, A; Pelayo, J; Rondeau, G; Welsh, J, 2017
)
3.34
"Plumbagin is a plant naphthoquinone which is present in several families, including Iridaceae, Plumbaginaceae, Ebenceae, Drosophyllaceae, Nepenthaceae and Droseraceae."( Biotechnological Approaches for the Production of Pharmaceutically Important Compound: Plumbagin.
Bharadvaja, N; Roy, A, 2018
)
1.43
"Plumbagin is an important phytocompound which shows potential towards treatments of various diseases. "( Biotechnological Approaches for the Production of Pharmaceutically Important Compound: Plumbagin.
Bharadvaja, N; Roy, A, 2018
)
2.15
"Plumbagin is a naphthoquinone present in the roots of Plumbago species which has hypolipidemic and hepatoprotective activities."( Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress.
Gaur, IS; Gursahani, MS; Juvekar, AR; Mestry, SN; Munshi, RP; Pai, SA; Panchal, FH, 2019
)
2.68
"Plumbagin thus seems to be a promising molecule for the management of obesity and NAFLD."( Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress.
Gaur, IS; Gursahani, MS; Juvekar, AR; Mestry, SN; Munshi, RP; Pai, SA; Panchal, FH, 2019
)
3.4
"Plumbagin is a naphthoquinone derived yellow crystalline phytochemical. "( Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy.
Biswal, BK; Panda, M; Tripathi, SK, 2019
)
2.3
"Plumbagin (PLB) is an active secondary metabolite extracted from the roots of Plumbago rosea. "( Plumbagin induces paraptosis in cancer cells by disrupting the sulfhydryl homeostasis and proteasomal function.
Binoy, A; Bose, C; Katiyar, N; Mishra, N; Nair, BG; Nedungadi, D; Shankarappa, SA, 2019
)
3.4
"Plumbagin is a major active constituent of Plumbago indica L. "( Increased production of plumbagin in Plumbago indica root cultures by gamma ray irradiation.
Jaisi, A; Panichayupakaranant, P; Sakunphueak, A, 2013
)
2.14
"Plumbagin is a plant naphtoquinone exerting anti-cancer properties including apoptotic cell death induction and generation of reactive oxygen species (ROS). "( Plumbagin modulates leukemia cell redox status.
Bagrel, D; Cerella, C; Dicato, M; Diederich, M; Gaascht, F; Teiten, MH, 2014
)
3.29
"Plumbagin is a nutraceutical with potent anti-cancer activity. "( Caging of plumbagin on silver nanoparticles imparts selectivity and sensitivity to plumbagin for targeted cancer cell apoptosis.
Duraipandy, N; K, PS; Kiran, MS; Kunnavakkam Vinjimur, S; Lakra, R; Samanta, D, 2014
)
2.25
"Plumbagin is a potent antioxidant and shows anti-carcinogenic, anti-inflammatory and analgesic activities."( Plumbagin Protects Against Spinal Cord Injury-induced Oxidative Stress and Inflammation in Wistar Rats through Nrf-2 Upregulation.
Cheng, L; Hou, Y; Nie, L; Si, M; Zhang, W; Zhao, YP, 2015
)
2.58
"Plumbagin is a plant-derived naphthoquinone, a natural product that exhibits antibacterial activity against gram-positive bacteria."( Proteomics analyses of Bacillus subtilis after treatment with plumbagin, a plant-derived naphthoquinone.
Panda, D; Prasad, TS; Rapole, S; Ray, S; Reddy, PJ; Sathe, GJ; Srivastava, S, 2015
)
1.38
"Plumbagin is a natural compound that is isolated from the root of the medicinal plant Plumbago zeylanica L. "( Plumbagin inhibits growth of gliomas in vivo via suppression of FOXM1 expression.
Cai, W; Chong, Y; Gao, S; Hu, W; Liu, H; Liu, X; Niu, M; Shi, Q; Yu, R; Zhou, X, 2015
)
3.3
"Plumbagin is a secondary metabolite that was first identified in the Plumbago genus of plants. "( The role of thioredoxin reductase and glutathione reductase in plumbagin-induced, reactive oxygen species-mediated apoptosis in cancer cell lines.
Bae, JS; Chang, W; Choi, J; Han, HJ; Hwang, GH; Jee, JG; Jeon, YJ; Jung, JW; Kim, LK; Lee, MY; Lee, S; Lee, YM; Ryu, JM, 2015
)
2.1
"Plumbagin is a derivative of napthoquinone which is isolated from the roots of plants in several families. "( Application of SPECT/CT imaging system and radiochemical analysis for investigation of blood kinetics and tissue distribution of radiolabeled plumbagin in healthy and Plasmodium berghei-infected mice.
Karbwang, J; Na-Bangchang, K; Sumsakul, W, 2016
)
2.08
"Plumbagin is a natural, plant derived compound, which exerts an anti-proliferative activity against many types of human cancer."( Plumbagin exerts an immunosuppressive effect on human T-cell acute lymphoblastic leukemia MOLT-4 cells.
Bae, KJ; Kim, J; Kim, SA; Lee, Y, 2016
)
2.6
"Plumbagin is a plant-derived naphthoquinone metabolite (5-hydroxy-2-methyl-1,4-naphthoquinone) reported to inhibit trypanothione reductase, the principal enzyme and a validated drug target involved in detoxification of oxidative stress in Leishmania."( Plumbagin, a plant-derived naphthoquinone metabolite induces mitochondria mediated apoptosis-like cell death in Leishmania donovani: an ultrastructural and physiological study.
Awasthi, BP; Kathuria, M; Kumari, N; Mitra, K; Pant, G, 2016
)
2.6
"Plumbagin (PLB) is a natural naphthoquinone with significant anticancer effects against several types of tumor cells including breast cancer."( Plumbagin Enhances Tamoxifen Sensitivity and Inhibits Tumor Invasion in Endocrine Resistant Breast Cancer through EMT Regulation.
Kalpongnukul, N; Ketchart, W; Pisitkun, T; Sakunrangsit, N, 2016
)
2.6
"Plumbagin is a quinonoid constituent extracted from Plumbago genus, and it exhibits diverse pharmacological effects. "( Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production.
Cheng, X; Da, Y; Gao, F; Guan, Z; Kong, L; Li, D; Li, Y; Miao, G; Qiao, L; Wang, D; Wang, H; Xue, Z; Yang, F; Yang, L; Yao, Z; Zhang, H; Zhang, L; Zhang, Q; Zhang, R; Zhang, Y, 2016
)
3.32
"Plumbagin is a natural quinonoid compound isolated from plant."( Plumbagin enhances TRAIL-mediated apoptosis through up-regulation of death receptor in human melanoma A375 cells.
Chen, R; Jiang, P; Li, J; Li, Y; Lu, J; Peng, R; Shen, Q; Zhang, L, 2010
)
2.52
"Plumbagin is a naturally occurring naphthoquinone isolated from roots of Plumbago scandens. "( Antimicrobial activity in vitro of plumbagin isolated from Plumbago species.
Aragão, TV; de Paiva, SR; Figueiredo, MR; Kaplan, MA, 2003
)
2.04
"Plumbagin is a naturally occurring naphthoquinone that can be obtained from roots of Plumbago scandens L."( Plumbagin quantification in roots of Plumbago scandens L. obtained by different extraction techniques.
de Paiva, SR; Figueiredo, MR; Kaplan, MA; Lima, LA, 2004
)
2.49

Effects

Plumbagin has a narrow therapeutic window, and literature reveals that the compound has moderate toxicity in animals. It has a wide range of biological effects including cytotoxicity against cancer cells.

Plumbagin (PLB) has been shown to have anticancer activities in animal models. The role of PLB in prostate cancer treatment is unclear. Plumbagin has shown no signs of toxicity at either of these doses.

ExcerptReferenceRelevance
"Plumbagin has a narrow therapeutic window, and literature reveals that the compound has moderate toxicity in animals."( Plumbagin: A Potential Candidate for Future Research and Development.
Janathia, B; Thakor, N, 2022
)
2.89
"Plumbagin has a wide range of biological effects including cytotoxicity against cancer cells both in vitro and in vivo."( Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy.
Biswal, BK; Panda, M; Tripathi, SK, 2019
)
1.57
"Plumbagin has gained a lot of attention in research due to its various therapeutic actions. "( Plumbagin: A Potential Candidate for Future Research and Development.
Janathia, B; Thakor, N, 2022
)
3.61
"Plumbagin (PLB) has many positive effects on human health."( Plumbagin alleviates obesity-related asthma: Targeting inflammation, oxidative stress, and the AMPK pathway.
Liang, D; Liu, L; Zhang, L, 2023
)
3.07
"Plumbagin (PL) has been shown to effectively inhibit tumor growth and migration of hepatocellular carcinoma cells in previous studies, but the specific mechanism for this remains unclear. "( Plumbagin promotes human hepatoma SMMC-7721 cell apoptosis via caspase-3/vimentin signal-mediated EMT.
Chen, Y; Lin, Y; Lv, B; Ma, J; Peng, Y; Wang, S; Wei, Y; Xie, J; Zhang, Y; Zhong, J, 2019
)
3.4
"Plumbagin has been identified as a potential natural product with multiple medical benefits; however, it remains largely unclear whether plumbagin can act against amyloid formation of proteins."( Evidence of Anti-amyloid Characteristics of Plumbagin via Inhibition of Protein Aggregation and Disassembly of Protein Fibrils.
Anand, BG; Ansari, M; Behera, RK; Kar, K; Kaushik, B; Panigrahi, A; Prajapati, KP; Purohit, S, 2021
)
1.6
"Plumbagin has been tested for anti-cancer activity in vitro and in vivo using mice model."( Chemosuppressive effect of plumbagin on human non-small lung cancer cell xenotransplanted zebrafish.
Ceasar, SA; Divyarupa, A; Vinothkumar, R,
)
1.15
"Plumbagin has anticancer activity toward several tumor types, but its effects on LCLC are unknown."( Plumbagin suppresses the human large cell lung cancer cell lines by inhibiting IL-6/STAT3 signaling in vitro.
Li, KY; Liu, G; Shao, Y; Xu, YY; Yu, T; Zhang, YY, 2018
)
2.64
"Plumbagin has a wide range of biological effects including cytotoxicity against cancer cells both in vitro and in vivo."( Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy.
Biswal, BK; Panda, M; Tripathi, SK, 2019
)
1.57
"Plumbagin has been reported to modulate cellular redox status and suppress NF-κB. "( Plumbagin, a vitamin K3 analogue, abrogates lipopolysaccharide-induced oxidative stress, inflammation and endotoxic shock via NF-κB suppression.
Checker, R; Menon, J; Patwardhan, RS; Poduval, TB; Sainis, KB; Sandur, SK; Sharma, D; Thoh, M, 2014
)
3.29
"Plumbagin (PLB) has shown anti-cancer activity but the mechanism is unclear. "( Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells.
Chow, K; Duan, W; He, SM; He, ZX; Huang, GH; Li, M; Li, YC; Liu, A; Liu, JP; Pang, JX; Qiu, JX; Yang, T; Yang, Y; Zhang, X; Zhou, Q; Zhou, SF; Zhou, ZW, 2014
)
3.29
"Plumbagin (PL) has been reported to exhibit anti-carcinogenic, anti-inflammatory and analgesic activities, but little is known about its mechanism. "( Plumbagin inhibits LPS-induced inflammation through the inactivation of the nuclear factor-kappa B and mitogen activated protein kinase signaling pathways in RAW 264.7 cells.
Jin, Z; Tang, T; Tu, B; Wang, T; Wang, Y; Wu, F; Yan, W; Zhai, Z, 2014
)
3.29
"Plumbagin has received extensive attention as a promising anticancer drug. "( Binding and Anticancer Properties of Plumbagin with Human Serum Albumin.
Gou, Y; Kong, L; Liang, H; Liang, S; Qi, J; Yang, F; Zhang, Y; Zhou, Z, 2015
)
2.13
"Plumbagin (PLB) has exhibited a potent anticancer effect in preclinical studies, but the molecular interactome remains elusive. "( Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
He, ZX; Mao, ZF; Qiu, JX; Yang, L; Zhang, X; Zhao, RJ; Zhou, SF; Zhou, ZW, 2015
)
3.3
"Plumbagin has shown no signs of toxicity at either of these doses."( Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.
Fischer, JW; Hafeez, BB; Meske, L; Mustafa, A; Sheikhani, MO; Singh, A; Verma, AK; Zhong, W, 2015
)
2.58
"Plumbagin (PLB) has been shown to have anticancer activities in animal models, but the role of PLB in prostate cancer treatment is unclear. "( Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells.
Chow, K; He, ZX; Li, XX; Pan, ST; Qiu, JX; Tan, J; Wang, D; Yang, T; Yang, Y; Zhang, X; Zhou, Q; Zhou, SF; Zhou, ZW, 2015
)
2.08
"Plumbagin has been reported to be neuroprotective, so it might possess antidepressant activity. "( Antidepressant-like activity of plumbagin in unstressed and stressed mice.
Bansal, S; Dhingra, D, 2015
)
2.14
"Plumbagin has exhibited its potential therapeutic benefits on numerous chronic diseases, i.e., breast cancer, non-small cell lung cancer, melanoma, ovarian, squamous cell carcinomas, pancreatic cancer, and prostate cancer."( Plumbagin and Its Role in Chronic Diseases.
Ahmad, MI; Panichayupakaranant, P, 2016
)
2.6
"Plumbagin has been reported to have several clinically relevant biological activities in non-neural cells, including anti-atherosclerotic, anticoagulant, anticarcinogenic, antitumor, and bactericidal effects."( Plumbagin promotes the generation of astrocytes from rat spinal cord neural progenitors via activation of the transcription factor Stat3.
Greig, NH; Jiang, H; Luo, W; Luo, Y; Mattson, MP; Mughal, MR; Ouyang, TG; Yu, QS, 2010
)
2.52
"Plumbagin has exhibited effective cell growth inhibition by inducing cancer cells to undergo G2/M phase arrest and apoptosis."( Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Cho, CY; Hsu, YL; Huang, YT; Kuo, PL; Lin, CC, 2006
)
2.5

Actions

Plumbagin reportedly displays anti-inflammatory, anti-fibrotic, antioxidant and anthelmintic properties. Plumbagin could inhibit the growth of TSCC PDX models and inhibit expression of Akt/mTOR pathway.

ExcerptReferenceRelevance
"Plumbagin reportedly displays anti-inflammatory, anti-fibrotic, antioxidant and anthelmintic properties."( Anti-inflammatory, antioxidant, anti-fibrotic and schistosomicidal properties of plumbagin in murine schistosomiasis.
Abdel-Latif, M; Abuelsaad, ASA; Allam, GA; Bakery, HH; Elkenawy, AE; Khalil, RG, 2022
)
1.67
"Plumbagin could inhibit the growth of TSCC PDX models and inhibit expression of Akt/mTOR pathway. "( Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin.
Jiang, Q; Liu, C; Qiu, J; Xin, Y, 2023
)
3.8
"The plumbagin-induced increase in DR4 and DR5 was inhibited by treatment with NAC."( Plumbagin treatment leads to apoptosis in human K562 leukemia cells through increased ROS and elevated TRAIL receptor expression.
McKallip, RJ; Sun, J, 2011
)
2.29
"Plumbagin did not produce the positive inotropic effects under anoxic conditions or in the presence of mitochondrial oxidative phosphorylation inhibitors such as 2,4-dinitrophenol and dicumarol."( Cardiotonic action of plumbagin on guinea-pig papillary muscle.
Furukawa, H; Itoigawa, M; Takeya, K, 1991
)
1.32

Treatment

Plumbagin pre-treatment prevented EGF-induced survival, clonogenesis, migration, matrix metalloproteinase -2 (MMP-2) gene expression and its secretion, and matrix protein hyaluron production in PANC-1 cells. Upon plumbagin treatment, reactive oxygen species content of the cancer cells escalated and prompted alleviation of the mitochondrial membrane potential, which triggers caspase-dependent apoptosis.

ExcerptReferenceRelevance
"Plumbagin treatment restored hepatic enzymes activity to nearly normal levels and induced an increase in catalase, SOD, GSH, total thiol and GST in liver tissue homogenate."( Anti-inflammatory, antioxidant, anti-fibrotic and schistosomicidal properties of plumbagin in murine schistosomiasis.
Abdel-Latif, M; Abuelsaad, ASA; Allam, GA; Bakery, HH; Elkenawy, AE; Khalil, RG, 2022
)
1.67
"Plumbagin treatment suppresses the WTAP-mediated N6-methylation of ASC mRNA and reduces the pyroptosis of GCs."( Plumbagin rescues the granulosa cell's pyroptosis by reducing WTAP-mediated N6-methylation in polycystic ovary syndrome.
Cai, Z; He, S; Liu, R; Zhao, L; Zhou, L, 2022
)
2.89
"Plumbagin pre-treatment significantly prevented EGF-induced survival, epithelial-to-mesenchymal transition (EMT), clonogenesis, migration, matrix metalloproteinase -2 (MMP-2) gene expression and its secretion, and matrix protein hyaluron production in PANC-1 cells."( Plumbagin binds to epidermal growth factor receptor and mitigate the effects of epidermal growth factor micro-environment in PANC-1 cells.
Murugantham, B; Muthusami, S; Periyasamy, L, 2023
)
3.07
"Upon plumbagin treatment, reactive oxygen species content of the cancer cells escalated and prompted alleviation of the mitochondrial membrane potential, which triggers caspase-dependent apoptosis."( Prooxidative activity of plumbagin induces apoptosis in human pancreatic ductal adenocarcinoma cells via intrinsic apoptotic pathway.
Biswal, BK; Panda, M; Pandey, K; Tripathi, SK, 2020
)
1.32
"The plumbagin treatment also assuaged the overexpression of inflammatory and apoptotic proteins in the heart tissues of doxorubicin-challenged rats."( Plumbagin protects the myocardial damage by modulating the cardiac biomarkers, antioxidants, and apoptosis signaling in the doxorubicin-induced cardiotoxicity in rats.
Ali Alharbi, S; Chinnathambi, A; Li, Z; Yin, F, 2020
)
2.48
"Plumbagin treatment (10 and 20mg/kg, po) significantly and dose-dependently reversed mechanical hyperalgesia and other functional deficits."( Nrf2 and NF-κB modulation by Plumbagin attenuates functional, behavioural and biochemical deficits in rat model of neuropathic pain.
Areti, A; Arruri, V; Dungavath, SKN; Komirishetty, P; Kumar, A, 2017
)
1.47
"Plumbagin treatment increased the proportion of cells in the G0/G1 phase of the cell cycle and decreased the proportion of cells in the S phase."( Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3.
Cao, Y; Jia, Y; Liu, B; Shang, M; Wu, S; Yin, X, 2018
)
2.64
"In plumbagin-treated HepG2 cells, reduced TP53, MAPK1 protein expressions were observed, accompanied with cell arrest and apoptosis."( Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma.
Li, R; Su, M; Wu, K; Zhou, R, 2019
)
1.25
"Plumbagin treatment significantly reduced MAPkinase and NF-κB activation in macrophages."( Plumbagin, a vitamin K3 analogue, abrogates lipopolysaccharide-induced oxidative stress, inflammation and endotoxic shock via NF-κB suppression.
Checker, R; Menon, J; Patwardhan, RS; Poduval, TB; Sainis, KB; Sandur, SK; Sharma, D; Thoh, M, 2014
)
2.57
"Plumbagin treatment significantly ameliorated oxidative stress through inhibition of ROS and lipid peroxidation with a concomitant increase in antioxidant status. "( Plumbagin Protects Against Spinal Cord Injury-induced Oxidative Stress and Inflammation in Wistar Rats through Nrf-2 Upregulation.
Cheng, L; Hou, Y; Nie, L; Si, M; Zhang, W; Zhao, YP, 2015
)
3.3
"Plumbagin treatment resulted in a decrease expression of PKCε, AKT, Stat3, and COX2 compared with the control mice."( Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.
Fischer, JW; Hafeez, BB; Meske, L; Mustafa, A; Sheikhani, MO; Singh, A; Verma, AK; Zhong, W, 2015
)
2.58
"Plumbagin treatment significantly reversed the levels of oxidative stress and apoptotic markers and protected against DEX-induced cell damage."( Plumbagin protects against glucocorticoid-induced osteoporosis through Nrf-2 pathway.
Li, D; Yan, TB; Yang, JY; Zhang, S, 2015
)
2.58
"Plumbagin treatment resulted in the induction of DNA damage, cell cycle arrest and apoptosis, followed by suppression of the colony forming ability of the brain tumour cells."( Plumbagin alters telomere dynamics, induces DNA damage and cell death in human brain tumour cells.
Hande, MP; Kalthur, G; Khaw, AK; Sameni, S; Venkatesan, S, 2015
)
2.58
"Plumbagin treatment induced cytotoxicity in human breast cancer cells along with cell cycle arrest, DNA damage and cell death leading to apoptosis. "( Plumbagin triggers DNA damage response, telomere dysfunction and genome instability of human breast cancer cells.
Hande, MP; Sameni, S, 2016
)
3.32
"Plumbagin treatment increased AMPK phosphorylation and attenuated NF-κB, STAT3, and Akt/mTOR signals in LX-2 cells, while SMAD2 phosphorylation was not changed."( Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production.
Cheng, X; Da, Y; Gao, F; Guan, Z; Kong, L; Li, D; Li, Y; Miao, G; Qiao, L; Wang, D; Wang, H; Xue, Z; Yang, F; Yang, L; Yao, Z; Zhang, H; Zhang, L; Zhang, Q; Zhang, R; Zhang, Y, 2016
)
2.6
"Plumbagin treatment caused a S-G(2)/M phase arrest and cell death of both MEF cell lines, induced p21 levels, and decreased p21-mediated long-patch (LP) BER by blocking DNA ligase activity in the polbeta-dependent pathway and by blocking both FEN1 and DNA ligase activity in polbeta-independent pathway."( Long-patch base excision repair of apurinic/apyrimidinic site DNA is decreased in mouse embryonic fibroblast cell lines treated with plumbagin: involvement of cyclin-dependent kinase inhibitor p21Waf-1/Cip-1.
Bloom, LB; Jaiswal, AS; Narayan, S, 2002
)
1.24
"Plumbagin treatment also enhanced the levels of inactivated phosphorylated Cdc2 and Cdc25C."( Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Cho, CY; Hsu, YL; Huang, YT; Kuo, PL; Lin, CC, 2006
)
2.5
"Plumbagin treatment decreased viability of human prostate cancer cells (PC-3, LNCaP, and C4-2) irrespective of their androgen responsiveness or p53 status. "( Plumbagin-induced apoptosis in human prostate cancer cells is associated with modulation of cellular redox status and generation of reactive oxygen species.
Powolny, AA; Singh, SV, 2008
)
3.23
"Plumbagin treated hyperlipidaemic subjects excreted more fecal cholesterol and phospholipids."( Hypolipidaemic and antiatherosclerotic effects of plumbagin in rabbits.
Dixit, VP; Gusain, D; Sharma, I, 1991
)
1.26
"Plumbagin treatment did not induce lambda phage in a lysogen, nor did it cause an increase in beta-galactosidase production in a dinD::Mu d(lac Ap) promoter fusion strain."( Toxicity and mutagenicity of plumbagin and the induction of a possible new DNA repair pathway in Escherichia coli.
Farr, SB; Kogoma, T; Natvig, DO, 1985
)
1.28
"Pretreatment with plumbagin markedly improved hepatic function and structural integrity compared to the I/R group, as manifested by depressed plasma transaminases and lactate dehydrogenase (LDH) activities as well as alleviated tissue pathological lesions."( Plumbagin ameliorates hepatic ischemia-reperfusion injury in rats: Role of high mobility group box 1 in inflammation, oxidative stress and apoptosis.
Abdelsalam, RM; El-Tanbouly, DM; Zaki, AM; Zaki, HF, 2018
)
2.25
"Pretreatment with plumbagin prevented Aβ25-35-induced toxicity by improving the cell viability up to 96%."( Plumbagin inhibits amyloid-β-induced neurotoxicity: regulation of oxidative stress and nuclear factor erythroid 2-related factor 2 activation.
Wang, S; Zhang, Z; Zhao, S, 2018
)
2.25
"Treatment with plumbagin increased the intracellular level of ROS, and inhibited the activation of NK-κB."( Plumbagin from Plumbago Zeylanica L induces apoptosis in human non-small cell lung cancer cell lines through NF- κB inactivation.
Liu, LX; Shen, H; Shu, YQ; Xu, TP, 2013
)
2.17
"Treatment with plumbagin significantly increased the viability of the H2O2-exposed NPCs in a dose‑dependent manner."( Plumbagin exerts protective effects in nucleus pulposus cells by attenuating hydrogen peroxide-induced oxidative stress, inflammation and apoptosis through NF-κB and Nrf-2.
Chu, H; Huang, H; Ren, D; Yu, H; Zhu, K, 2016
)
2.22

Toxicity

Plumbagin crude extract found to be highly toxic to normal cells. Niosome-encapsulated plumbagin was less toxic than free drug.

ExcerptReferenceRelevance
" sanguis, O2- can exert a toxic effect independent of the production of OH."( Oxygen toxicity in Streptococcus sanguis. The relative importance of superoxide and hydroxyl radicals.
DiGuiseppi, J; Fridovich, I, 1982
)
0.26
" Niosome-encapsulated plumbagin was less toxic than free drug."( Niosomal plumbagin with reduced toxicity and improved anticancer activity in BALB/C mice.
Devi, PU; Naresh, RA; Udupa, N, 1996
)
1.03
" However, the results showed that, even by different pathways, both drugs were capable of generating oxidative stress through their toxic effects."( Cytotoxicity mechanism of two naphthoquinones (menadione and plumbagin) in Saccharomyces cerevisiae.
Castro, FA; Eleutherio, EC; Mariani, D; Panek, AD; Pereira, MD, 2008
)
0.59
" However, plumbagin crude extract found to be highly toxic to normal cells when compared to plumbagin nanoformulation, thus confirming nano plumbagin cytocompatibility with normal cells and dose dependent toxicity to prostate cells."( Plumbagin Nanoparticles Induce Dose and pH Dependent Toxicity on Prostate Cancer Cells.
Kamath, RC; Lakshmanan, VK; Nair, HA; Nair, SV; Snima, KS, 2015
)
2.26

Pharmacokinetics

The pharmacokinetic profile of plumbagin following a single oral dose of 100 mg/kg body weight suggests that delayed absorption and short residence time (median values of time to maximal concentration and elimination half-life = 9. Pharmacokinetic property of this compound may be a limiting factor that explains the weak antimalarial activity of Plumbagin observed in animal models.

ExcerptReferenceRelevance
" Pharmacokinetic studies showed a 22."( Preparation, in vitro characterization, pharmacokinetic, and pharmacodynamic evaluation of chitosan-based plumbagin microspheres in mice bearing B16F1 melanoma.
Aithal, K; Anandam, A; Arumugam, K; Bhat, K; Bola Sadashiva, SR; Mandala Rayabandla, SK; Musmade, P; Nayanabhirama, U; Shavi, G, 2010
)
0.57
" The aim of the study was to investigate the pharmacokinetic profile following a single oral dosing to explain inconsistency of results of the in vitro and in vivo antimalarial activities."( Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin.
Na-Bangchang, K; Plengsuriyakarn, T; Sumsakul, W, 2016
)
0.67
" The pharmacokinetic profile of plumbagin following a single oral dose of 100 mg/kg body weight suggests that delayed absorption and short residence time (median values of time to maximal concentration and elimination half-life = 9."( Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin.
Na-Bangchang, K; Plengsuriyakarn, T; Sumsakul, W, 2016
)
0.95
" Pharmacokinetic property of this compound may be a limiting factor that explains the weak antimalarial activity of plumbagin observed in animal models."( Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin.
Na-Bangchang, K; Plengsuriyakarn, T; Sumsakul, W, 2016
)
0.88

Compound-Compound Interactions

ExcerptReferenceRelevance
"The aim of the present study was to investigate the protective effect exerted by bone marrow mesenchymal stem cells (BMSCs) in combination with plumbagin on spinal cord injury (SCI) and explore the mechanism behind this protective effect."( Treatment with bone marrow mesenchymal stem cells combined with plumbagin alleviates spinal cord injury by affecting oxidative stress, inflammation, apoptotis and the activation of the Nrf2 pathway.
Liang, M; Song, J; Yang, JY; Yang, W; Yang, Y, 2016
)
0.87

Bioavailability

Nano encapsulation of plumbagin overcomes the poor water solubility and bioavailability obstacles, enhancing the pharmaceutical relevance with better therapeutic efficacy.

ExcerptReferenceRelevance
"The aim of the present study is to develop an automated blood sampling (ABS) method coupled to a liquid chromatography-tandem mass spectroscopy (LC-MS/MS) method to evaluate the oral bioavailability of plumbagin in a conscious freely moving rat."( Measurement and pharmacokinetic study of plumbagin in a conscious freely moving rat using liquid chromatography/tandem mass spectrometry.
Hsieh, YJ; Lin, LC; Tsai, TH, 2006
)
0.79
"Various shortcomings of the available methods of extraction of plumbagin from Plumbago zeylanica using non-edible organic solvents coupled with the poor aqueous solubility and low bioavailability called for extracting plumbagin in a water soluble form via a single step technique using hydrophilic lipid Gelucire 44/14."( Novel solvent-free gelucire extract of Plumbago zeylanica using non-everted rat intestinal sac method for improved therapeutic efficacy of plumbagin.
Bothiraja, C; Dama, GY; Joshi, PP; Pawar, AP; Shaikh, KS, 2012
)
0.82
" In vitro intestinal absorption and bioavailability of plumbagin from GPZ in comparison with that of aqueous (APZ), ethanolic extract (EPZ) and standard plumbagin studied using non-everted rat intestinal sac model."( Novel solvent-free gelucire extract of Plumbago zeylanica using non-everted rat intestinal sac method for improved therapeutic efficacy of plumbagin.
Bothiraja, C; Dama, GY; Joshi, PP; Pawar, AP; Shaikh, KS, 2012
)
0.83
" However, this approach is frequently limited by the bioavailability and toxicity of the combined agents and delivery at ratios to specific locations that synergistically kill cancer cells."( Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma.
Gowda, R; Kardos, G; Robertson, GP; Sharma, A; Singh, S, 2017
)
0.74
" However, its lower bioavailability limits biopharmaceutical properties due to insolubility in water."( Plumbagin-loaded aptamer-targeted poly D,L-lactic-co-glycolic acid-b-polyethylene glycol nanoparticles for prostate cancer therapy.
Ju, W; Li, W; Li, Z; Pan, M; Xiao, Y; Xing, Y; Yang, J; Zhang, X; Zhao, J, 2017
)
1.9
" Nano encapsulation of plumbagin overcomes the poor water solubility and bioavailability obstacles, enhancing the pharmaceutical relevance with better therapeutic efficacy."( Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy.
Biswal, BK; Panda, M; Tripathi, SK, 2019
)
1.16
" An overview of attempts to design novel formulations which could enhance its bioavailability is also presented."( Plumbagin: A Potential Candidate for Future Research and Development.
Janathia, B; Thakor, N, 2022
)
2.16

Dosage Studied

Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) isolated from Plumbago zeylanica Linn. When administered orally, at a dosage of 4 mg/kg body weight induces tumour regression in Wistar male rats.

ExcerptRelevanceReference
"The chitin synthetase inhibitor plumbagin and its 2-demethyl derivative juglone were found to inhibit in a dose-response fashion the cytochrome P-450 dependent ecdysone 20-monooxygenase activity associated with adult female Aedes aegypti, wandering stage larvae of Drosophila melanogaster, and fat body and midgut from last instar larvae of Manduca sexta."( Effects of the chitin synthetase inhibitor plumbagin and its 2-demethyl derivative juglone on insect ecdysone 20-monooxygenase activity.
Mitchell, MJ; Smith, SL, 1988
)
0.82
"Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) isolated from Plumbago zeylanica Linn, when administered orally, at a dosage of 4 mg/kg body weight induces tumour regression in 3-methyl-4-dimethyl aminoazobenzene (3MeDAB) induced hepatoma in Wistar male rats."( Effect of Plumbagin on some glucose metabolising enzymes studied in rats in experimental hepatoma.
Parimala, R; Sachdanandam, P, 1993
)
2.13
" Groups of female Sprague-Dawley rats were dosed by oral intubation on 5 consecutive days with either juglone or plumbagin at 12."( Induction of quinone reductase and glutathione transferase in rat tissues by juglone and plumbagin.
Munday, CM; Munday, R, 2000
)
0.74
" The observed responses varied according to dosage and mite species."( Acaricidal activity and function of mite indicator using plumbagin and its derivatives isolated from Diospyros kaki Thunb. roots (Ebenaceae).
Lee, CH; Lee, HS, 2008
)
0.59
" The aim of the study was to investigate the pharmacokinetic profile following a single oral dosing to explain inconsistency of results of the in vitro and in vivo antimalarial activities."( Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin.
Na-Bangchang, K; Plengsuriyakarn, T; Sumsakul, W, 2016
)
0.67
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
immunological adjuvantA substance that augments, stimulates, activates, potentiates, or modulates the immune response at either the cellular or humoral level. A classical agent (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contains bacterial antigens. It could also be endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Its mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy is related to its antigen-specific immunoadjuvanticity.
anticoagulantAn agent that prevents blood clotting.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
hydroxy-1,4-naphthoquinoneAny member of the class of 1,4-naphthoquinones in which the naphthoquinone moiety is substituted by at least one hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (7)

PathwayProteinsCompounds
tetrahydroxyxanthone biosynthesis (from 3-hydroxybenzoate)021
superpathway of tetrahydroxyxanthone biosynthesis026
(-)-maackiain biosynthesis016
superpathway of pterocarpan biosynthesis (via formononetin)031
plumbagin biosynthesis111
tetrahydroxyxanthone biosynthesis (from benzoate)022
superpathway of formononetin derivative biosynthesis031
(-)-maackiain biosynthesis217
tetrahydroxyxanthone biosynthesis (from 3-hydroxybenzoate)023
superpathway of pterocarpan biosynthesis (via formononetin)334
superpathway of tetrahydroxyxanthone biosynthesis028
superpathway of formononetin derivative biosynthesis234

Protein Targets (78)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency28.18380.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency39.81070.004023.8416100.0000AID485290
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency0.11190.140911.194039.8107AID2451
Chain A, HADH2 proteinHomo sapiens (human)Potency26.20000.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency26.20000.025120.237639.8107AID893
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency7.61110.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency22.38720.125919.1169125.8920AID2549
15-lipoxygenase, partialHomo sapiens (human)Potency3.16230.012610.691788.5700AID887
phosphopantetheinyl transferaseBacillus subtilisPotency35.48130.141337.9142100.0000AID1490
USP1 protein, partialHomo sapiens (human)Potency33.95070.031637.5844354.8130AID504865
TDP1 proteinHomo sapiens (human)Potency1.90960.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency1.71690.180013.557439.8107AID1460; AID1468
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency27.82980.011212.4002100.0000AID1030
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency5.22760.016525.307841.3999AID602332
Bloom syndrome protein isoform 1Homo sapiens (human)Potency31.62280.540617.639296.1227AID2528
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency5.27120.316212.443531.6228AID902; AID924
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency25.11890.001815.663839.8107AID894
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency4.41730.354828.065989.1251AID504847
mitogen-activated protein kinase 1Homo sapiens (human)Potency10.66390.039816.784239.8107AID1454; AID1725; AID995
dual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)Potency12.58930.10000.10000.1000AID1732
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency8.71250.00798.23321,122.0200AID2546; AID2551
DNA polymerase kappa isoform 1Homo sapiens (human)Potency10.00000.031622.3146100.0000AID588579
survival motor neuron protein isoform dHomo sapiens (human)Potency28.18380.125912.234435.4813AID1458
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency31.62280.031610.279239.8107AID884; AID885
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency39.81070.251215.843239.8107AID504327
caspase-1 isoform alpha precursorHomo sapiens (human)Potency22.10610.000311.448431.6228AID900
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Integrin beta-3Homo sapiens (human)Potency5.14530.316211.415731.6228AID924
Integrin alpha-IIbHomo sapiens (human)Potency5.14530.316211.415731.6228AID924
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)Potency12.58930.10000.10000.1000AID1732
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)Potency12.58930.10000.10000.1000AID1732
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)Potency12.58930.10000.10000.1000AID1732
Caspase-7Homo sapiens (human)Potency19.95263.981118.585631.6228AID889
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Inositol monophosphatase 1Rattus norvegicus (Norway rat)Potency13.55711.000010.475628.1838AID1457
GABA theta subunitRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)IC50 (µMol)30.80000.00010.545310.0000AID1062007
Cytochrome P450 1A1Homo sapiens (human)IC50 (µMol)2.77000.00791.24789.9000AID1411739
Cytochrome P450 1A1Homo sapiens (human)Ki2.56000.01200.94693.8000AID1411739
Cytochrome P450 1A2Homo sapiens (human)IC50 (µMol)2.46000.00011.774010.0000AID1411740
Cytochrome P450 1A2Homo sapiens (human)Ki2.36000.00561.15349.0000AID1411740
Cytochrome P450 3A4Homo sapiens (human)IC50 (µMol)10.00000.00011.753610.0000AID1411745
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusIC50 (µMol)17.10000.00402.92669.9600AID1805801
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2IC50 (µMol)17.10000.00022.45859.9600AID1805801
Cytochrome P450 2D6Homo sapiens (human)IC50 (µMol)10.00000.00002.015110.0000AID1411742
60 kDa heat shock protein, mitochondrialHomo sapiens (human)IC50 (µMol)6.30000.17004.559010.0000AID1594139
Cytochrome P450 2C9 Homo sapiens (human)IC50 (µMol)10.00000.00002.800510.0000AID1411743
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)3.00000.00002.37899.7700AID1801570
Trypanothione reductaseTrypanosoma cruziIC50 (µMol)28.00005.80005.80005.8000AID212727; AID214491
M-phase inducer phosphatase 1Homo sapiens (human)IC50 (µMol)0.70000.02204.20249.4000AID1517763
M-phase inducer phosphatase 2Homo sapiens (human)IC50 (µMol)3.10000.10002.31039.5100AID1517765
Cytochrome P450 2C19Homo sapiens (human)IC50 (µMol)10.00000.00002.398310.0000AID1411744
10 kDa heat shock protein, mitochondrialHomo sapiens (human)IC50 (µMol)6.30000.17004.559010.0000AID1594139
Histone acetyltransferase p300Homo sapiens (human)IC50 (µMol)15.50000.26004.00008.5000AID1282386; AID1282387; AID1607729; AID1607751
Cytochrome P450 1B1Homo sapiens (human)IC50 (µMol)6.15000.00130.86969.9000AID1411741
Thiosulfate sulfurtransferaseHomo sapiens (human)IC50 (µMol)0.06000.06003.96319.7000AID1594135
60 kDa chaperonin Escherichia coliIC50 (µMol)2.04500.03903.55529.8000AID1594140; AID1594141
10 kDa chaperonin Escherichia coliIC50 (µMol)2.04500.03903.55529.8000AID1594140; AID1594141
Histone acetyltransferase KAT2BHomo sapiens (human)IC50 (µMol)50.00005.00006.01678.5000AID1282388; AID1607730; AID1607752
Mitogen-activated protein kinase kinase kinase 14Homo sapiens (human)IC50 (µMol)100.00000.24401.27202.3000AID493445
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Dual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)Kd14.00000.02701.44715.3000AID1517764
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)0.46000.00033.166210.0000AID1625339
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA topoisomerase 1Homo sapiens (human)MIC50.00000.01002.00175.0000AID228426
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (418)

Processvia Protein(s)Taxonomy
apoptotic processDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
response to osmotic stressDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
signal transductionDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
JNK cascadeDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
response to heatDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
response to UVDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
response to woundingDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
positive regulation of telomere maintenance via telomeraseDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
response to tumor necrosis factorDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
Fc-epsilon receptor signaling pathwayDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
positive regulation of JUN kinase activityDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
positive regulation of DNA-templated transcriptionDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
positive regulation of JNK cascadeDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
stress-activated MAPK cascadeDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
positive regulation of telomerase activityDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
cellular response to lipopolysaccharideDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
cellular response to interleukin-1Dual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
cellular senescenceDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
positive regulation of telomere cappingDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
regulation of motor neuron apoptotic processDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
positive regulation of protein phosphorylationReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
protein phosphorylationReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
signal transductionReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
enzyme-linked receptor protein signaling pathwayReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
heart developmentReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
neuromuscular junction developmentReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
motor neuron axon guidanceReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
Schwann cell developmentReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
peptidyl-tyrosine phosphorylationReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
positive regulation of cell growthReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
regulation of microtubule-based processReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
immature T cell proliferation in thymusReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
negative regulation of immature T cell proliferation in thymusReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
positive regulation of Rho protein signal transductionReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
intracellular signal transductionReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
ERBB2-ERBB3 signaling pathwayReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
ERBB2-EGFR signaling pathwayReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
ERBB2-ERBB4 signaling pathwayReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
wound healingReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
myelinationReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
positive regulation of MAP kinase activityReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
positive regulation of translationReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
regulation of angiogenesisReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
positive regulation of cell adhesionReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
oligodendrocyte differentiationReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
positive regulation of epithelial cell proliferationReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
regulation of ERK1 and ERK2 cascadeReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
cellular response to growth factor stimulusReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
cellular response to epidermal growth factor stimulusReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
semaphorin-plexin signaling pathwayReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
positive regulation of protein targeting to membraneReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
neurotransmitter receptor localization to postsynaptic specialization membraneReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
neurogenesisReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
positive regulation of MAPK cascadeReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
negative regulation of apoptotic processReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
positive regulation of kinase activityReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
multicellular organism developmentReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
positive regulation of cell population proliferationReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
neuron differentiationReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
cellular response to organic cyclic compoundCytochrome P450 1A1Homo sapiens (human)
response to hypoxiaCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
lipid hydroxylationCytochrome P450 1A1Homo sapiens (human)
fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid metabolic processCytochrome P450 1A1Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A1Homo sapiens (human)
amine metabolic processCytochrome P450 1A1Homo sapiens (human)
response to nematodeCytochrome P450 1A1Homo sapiens (human)
response to herbicideCytochrome P450 1A1Homo sapiens (human)
ethylene metabolic processCytochrome P450 1A1Homo sapiens (human)
coumarin metabolic processCytochrome P450 1A1Homo sapiens (human)
flavonoid metabolic processCytochrome P450 1A1Homo sapiens (human)
response to iron(III) ionCytochrome P450 1A1Homo sapiens (human)
insecticide metabolic processCytochrome P450 1A1Homo sapiens (human)
dibenzo-p-dioxin catabolic processCytochrome P450 1A1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
response to foodCytochrome P450 1A1Homo sapiens (human)
response to lipopolysaccharideCytochrome P450 1A1Homo sapiens (human)
response to vitamin ACytochrome P450 1A1Homo sapiens (human)
response to immobilization stressCytochrome P450 1A1Homo sapiens (human)
vitamin D metabolic processCytochrome P450 1A1Homo sapiens (human)
retinol metabolic processCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
9-cis-retinoic acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
camera-type eye developmentCytochrome P450 1A1Homo sapiens (human)
nitric oxide metabolic processCytochrome P450 1A1Homo sapiens (human)
response to arsenic-containing substanceCytochrome P450 1A1Homo sapiens (human)
digestive tract developmentCytochrome P450 1A1Homo sapiens (human)
tissue remodelingCytochrome P450 1A1Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A1Homo sapiens (human)
response to hyperoxiaCytochrome P450 1A1Homo sapiens (human)
maternal process involved in parturitionCytochrome P450 1A1Homo sapiens (human)
hepatocyte differentiationCytochrome P450 1A1Homo sapiens (human)
cellular response to copper ionCytochrome P450 1A1Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleCytochrome P450 1A1Homo sapiens (human)
response to 3-methylcholanthreneCytochrome P450 1A1Homo sapiens (human)
negative regulation of low-density lipoprotein receptor activityIntegrin beta-3Homo sapiens (human)
positive regulation of protein phosphorylationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
cell-substrate junction assemblyIntegrin beta-3Homo sapiens (human)
cell adhesionIntegrin beta-3Homo sapiens (human)
cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
embryo implantationIntegrin beta-3Homo sapiens (human)
blood coagulationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of gene expressionIntegrin beta-3Homo sapiens (human)
negative regulation of macrophage derived foam cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-3Homo sapiens (human)
negative regulation of lipid storageIntegrin beta-3Homo sapiens (human)
response to activityIntegrin beta-3Homo sapiens (human)
smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
platelet activationIntegrin beta-3Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
cell-substrate adhesionIntegrin beta-3Homo sapiens (human)
activation of protein kinase activityIntegrin beta-3Homo sapiens (human)
negative regulation of lipid transportIntegrin beta-3Homo sapiens (human)
regulation of protein localizationIntegrin beta-3Homo sapiens (human)
regulation of actin cytoskeleton organizationIntegrin beta-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of osteoblast proliferationIntegrin beta-3Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-3Homo sapiens (human)
substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
tube developmentIntegrin beta-3Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-3Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusIntegrin beta-3Homo sapiens (human)
apolipoprotein A-I-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
wound healingIntegrin beta-3Homo sapiens (human)
apoptotic cell clearanceIntegrin beta-3Homo sapiens (human)
regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-3Homo sapiens (human)
positive regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
symbiont entry into host cellIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast proliferationIntegrin beta-3Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin beta-3Homo sapiens (human)
negative regulation of lipoprotein metabolic processIntegrin beta-3Homo sapiens (human)
negative chemotaxisIntegrin beta-3Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolIntegrin beta-3Homo sapiens (human)
regulation of serotonin uptakeIntegrin beta-3Homo sapiens (human)
angiogenesis involved in wound healingIntegrin beta-3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeIntegrin beta-3Homo sapiens (human)
platelet aggregationIntegrin beta-3Homo sapiens (human)
cellular response to mechanical stimulusIntegrin beta-3Homo sapiens (human)
cellular response to xenobiotic stimulusIntegrin beta-3Homo sapiens (human)
positive regulation of glomerular mesangial cell proliferationIntegrin beta-3Homo sapiens (human)
blood coagulation, fibrin clot formationIntegrin beta-3Homo sapiens (human)
maintenance of postsynaptic specialization structureIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor diffusion trappingIntegrin beta-3Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
regulation of trophoblast cell migrationIntegrin beta-3Homo sapiens (human)
regulation of extracellular matrix organizationIntegrin beta-3Homo sapiens (human)
cellular response to insulin-like growth factor stimulusIntegrin beta-3Homo sapiens (human)
negative regulation of endothelial cell apoptotic processIntegrin beta-3Homo sapiens (human)
positive regulation of T cell migrationIntegrin beta-3Homo sapiens (human)
cell migrationIntegrin beta-3Homo sapiens (human)
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-IIbHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-IIbHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-IIbHomo sapiens (human)
cell-cell adhesionIntegrin alpha-IIbHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-IIbHomo sapiens (human)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
protein folding60 kDa chaperoninEscherichia coli K-12
response to radiation60 kDa chaperoninEscherichia coli K-12
response to heat60 kDa chaperoninEscherichia coli K-12
virion assembly60 kDa chaperoninEscherichia coli K-12
chaperone cofactor-dependent protein refolding60 kDa chaperoninEscherichia coli K-12
protein refolding60 kDa chaperoninEscherichia coli K-12
chaperone cofactor-dependent protein refolding60 kDa chaperoninEscherichia coli K-12
response to heat60 kDa chaperoninEscherichia coli K-12
symbiont-mediated perturbation of host ubiquitin-like protein modificationReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
xenobiotic metabolic processCytochrome P450 2D6Homo sapiens (human)
steroid metabolic processCytochrome P450 2D6Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2D6Homo sapiens (human)
estrogen metabolic processCytochrome P450 2D6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid catabolic processCytochrome P450 2D6Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2D6Homo sapiens (human)
isoquinoline alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2D6Homo sapiens (human)
retinol metabolic processCytochrome P450 2D6Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2D6Homo sapiens (human)
negative regulation of bindingCytochrome P450 2D6Homo sapiens (human)
oxidative demethylationCytochrome P450 2D6Homo sapiens (human)
negative regulation of cellular organofluorine metabolic processCytochrome P450 2D6Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 2D6Homo sapiens (human)
adhesion of symbiont to host60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of type II interferon production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
MyD88-dependent toll-like receptor signaling pathway60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of T cell mediated immune response to tumor cell60 kDa heat shock protein, mitochondrialHomo sapiens (human)
'de novo' protein folding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to unfolded protein60 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to cold60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interferon-alpha production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of type II interferon production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-10 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-12 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-6 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein refolding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
B cell proliferation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
B cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of macrophage activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
negative regulation of apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
isotype switching to IgG isotypes60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein stabilization60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
chaperone-mediated protein complex assembly60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein maturation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
biological process involved in interaction with symbiont60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cellular response to interleukin-760 kDa heat shock protein, mitochondrialHomo sapiens (human)
T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein import into mitochondrial intermembrane space60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial unfolded protein response60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apoptotic mitochondrial changes60 kDa heat shock protein, mitochondrialHomo sapiens (human)
DNA topological changeDNA topoisomerase 1Homo sapiens (human)
chromatin remodelingDNA topoisomerase 1Homo sapiens (human)
circadian rhythmDNA topoisomerase 1Homo sapiens (human)
response to xenobiotic stimulusDNA topoisomerase 1Homo sapiens (human)
programmed cell deathDNA topoisomerase 1Homo sapiens (human)
phosphorylationDNA topoisomerase 1Homo sapiens (human)
peptidyl-serine phosphorylationDNA topoisomerase 1Homo sapiens (human)
circadian regulation of gene expressionDNA topoisomerase 1Homo sapiens (human)
embryonic cleavageDNA topoisomerase 1Homo sapiens (human)
chromosome segregationDNA topoisomerase 1Homo sapiens (human)
DNA replicationDNA topoisomerase 1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C9 Homo sapiens (human)
steroid metabolic processCytochrome P450 2C9 Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2C9 Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C9 Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C9 Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
urea metabolic processCytochrome P450 2C9 Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 2C9 Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C9 Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
amide metabolic processCytochrome P450 2C9 Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
oxidative demethylationCytochrome P450 2C9 Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activityM-phase inducer phosphatase 1Homo sapiens (human)
G1/S transition of mitotic cell cycleM-phase inducer phosphatase 1Homo sapiens (human)
G2/M transition of mitotic cell cycleM-phase inducer phosphatase 1Homo sapiens (human)
cell population proliferationM-phase inducer phosphatase 1Homo sapiens (human)
response to radiationM-phase inducer phosphatase 1Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleM-phase inducer phosphatase 1Homo sapiens (human)
cellular response to UVM-phase inducer phosphatase 1Homo sapiens (human)
positive regulation of DNA replicationM-phase inducer phosphatase 1Homo sapiens (human)
cell divisionM-phase inducer phosphatase 1Homo sapiens (human)
positive regulation of G2/MI transition of meiotic cell cycleM-phase inducer phosphatase 1Homo sapiens (human)
G2/M transition of mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
oocyte maturationM-phase inducer phosphatase 2Homo sapiens (human)
protein phosphorylationM-phase inducer phosphatase 2Homo sapiens (human)
female meiosis IM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of cell population proliferationM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of cytokinesisM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
cell divisionM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of G2/MI transition of meiotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 2C19Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C19Homo sapiens (human)
steroid metabolic processCytochrome P450 2C19Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C19Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C19Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
proteolysisCaspase-7Homo sapiens (human)
apoptotic processCaspase-7Homo sapiens (human)
heart developmentCaspase-7Homo sapiens (human)
response to UVCaspase-7Homo sapiens (human)
protein processingCaspase-7Homo sapiens (human)
protein catabolic processCaspase-7Homo sapiens (human)
defense response to bacteriumCaspase-7Homo sapiens (human)
fibroblast apoptotic processCaspase-7Homo sapiens (human)
striated muscle cell differentiationCaspase-7Homo sapiens (human)
neuron apoptotic processCaspase-7Homo sapiens (human)
protein maturationCaspase-7Homo sapiens (human)
lymphocyte apoptotic processCaspase-7Homo sapiens (human)
cellular response to lipopolysaccharideCaspase-7Homo sapiens (human)
cellular response to staurosporineCaspase-7Homo sapiens (human)
execution phase of apoptosisCaspase-7Homo sapiens (human)
positive regulation of plasma membrane repairCaspase-7Homo sapiens (human)
positive regulation of neuron apoptotic processCaspase-7Homo sapiens (human)
osteoblast differentiation10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic process10 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to unfolded protein10 kDa heat shock protein, mitochondrialHomo sapiens (human)
chaperone cofactor-dependent protein refolding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone acetyltransferase p300Homo sapiens (human)
response to hypoxiaHistone acetyltransferase p300Homo sapiens (human)
somitogenesisHistone acetyltransferase p300Homo sapiens (human)
thigmotaxisHistone acetyltransferase p300Homo sapiens (human)
behavioral defense responseHistone acetyltransferase p300Homo sapiens (human)
stimulatory C-type lectin receptor signaling pathwayHistone acetyltransferase p300Homo sapiens (human)
regulation of glycolytic processHistone acetyltransferase p300Homo sapiens (human)
protein acetylationHistone acetyltransferase p300Homo sapiens (human)
internal protein amino acid acetylationHistone acetyltransferase p300Homo sapiens (human)
apoptotic processHistone acetyltransferase p300Homo sapiens (human)
canonical NF-kappaB signal transductionHistone acetyltransferase p300Homo sapiens (human)
nervous system developmentHistone acetyltransferase p300Homo sapiens (human)
heart developmentHistone acetyltransferase p300Homo sapiens (human)
skeletal muscle tissue developmentHistone acetyltransferase p300Homo sapiens (human)
learning or memoryHistone acetyltransferase p300Homo sapiens (human)
circadian rhythmHistone acetyltransferase p300Homo sapiens (human)
animal organ morphogenesisHistone acetyltransferase p300Homo sapiens (human)
regulation of autophagyHistone acetyltransferase p300Homo sapiens (human)
negative regulation of autophagyHistone acetyltransferase p300Homo sapiens (human)
macrophage derived foam cell differentiationHistone acetyltransferase p300Homo sapiens (human)
regulation of mitochondrion organizationHistone acetyltransferase p300Homo sapiens (human)
positive regulation of neuron projection developmentHistone acetyltransferase p300Homo sapiens (human)
N-terminal peptidyl-lysine acetylationHistone acetyltransferase p300Homo sapiens (human)
internal peptidyl-lysine acetylationHistone acetyltransferase p300Homo sapiens (human)
peptidyl-lysine acetylationHistone acetyltransferase p300Homo sapiens (human)
B cell differentiationHistone acetyltransferase p300Homo sapiens (human)
platelet formationHistone acetyltransferase p300Homo sapiens (human)
lung developmentHistone acetyltransferase p300Homo sapiens (human)
positive regulation of transforming growth factor beta receptor signaling pathwayHistone acetyltransferase p300Homo sapiens (human)
negative regulation of protein-containing complex assemblyHistone acetyltransferase p300Homo sapiens (human)
protein destabilizationHistone acetyltransferase p300Homo sapiens (human)
cellular response to nutrient levelsHistone acetyltransferase p300Homo sapiens (human)
cellular response to UVHistone acetyltransferase p300Homo sapiens (human)
multicellular organism growthHistone acetyltransferase p300Homo sapiens (human)
megakaryocyte developmentHistone acetyltransferase p300Homo sapiens (human)
swimmingHistone acetyltransferase p300Homo sapiens (human)
positive regulation of protein import into nucleusHistone acetyltransferase p300Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorHistone acetyltransferase p300Homo sapiens (human)
response to estrogenHistone acetyltransferase p300Homo sapiens (human)
positive regulation by host of viral transcriptionHistone acetyltransferase p300Homo sapiens (human)
fat cell differentiationHistone acetyltransferase p300Homo sapiens (human)
negative regulation of gluconeogenesisHistone acetyltransferase p300Homo sapiens (human)
transcription initiation-coupled chromatin remodelingHistone acetyltransferase p300Homo sapiens (human)
positive regulation of DNA-templated transcriptionHistone acetyltransferase p300Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone acetyltransferase p300Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATHistone acetyltransferase p300Homo sapiens (human)
protein stabilizationHistone acetyltransferase p300Homo sapiens (human)
positive regulation of DNA-binding transcription factor activityHistone acetyltransferase p300Homo sapiens (human)
face morphogenesisHistone acetyltransferase p300Homo sapiens (human)
regulation of androgen receptor signaling pathwayHistone acetyltransferase p300Homo sapiens (human)
peptidyl-lysine propionylationHistone acetyltransferase p300Homo sapiens (human)
cellular response to L-leucineHistone acetyltransferase p300Homo sapiens (human)
regulation of tubulin deacetylationHistone acetyltransferase p300Homo sapiens (human)
peptidyl-lysine crotonylationHistone acetyltransferase p300Homo sapiens (human)
peptidyl-lysine butyrylationHistone acetyltransferase p300Homo sapiens (human)
regulation of cellular response to heatHistone acetyltransferase p300Homo sapiens (human)
regulation of signal transduction by p53 class mediatorHistone acetyltransferase p300Homo sapiens (human)
positive regulation of TORC1 signalingHistone acetyltransferase p300Homo sapiens (human)
positive regulation of T-helper 17 cell lineage commitmentHistone acetyltransferase p300Homo sapiens (human)
peptide hormone processingPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
low-density lipoprotein particle remodelingPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
lipid oxidationPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
plasma lipoprotein particle oxidationPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
phosphatidylcholine catabolic processPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
platelet activating factor metabolic processPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
positive regulation of inflammatory responsePlatelet-activating factor acetylhydrolaseHomo sapiens (human)
platelet activating factor catabolic processPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
positive regulation of monocyte chemotaxisPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
cellular response to organic cyclic compoundCytochrome P450 1B1Homo sapiens (human)
angiogenesisCytochrome P450 1B1Homo sapiens (human)
trabecular meshwork developmentCytochrome P450 1B1Homo sapiens (human)
DNA modificationCytochrome P450 1B1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1B1Homo sapiens (human)
nitric oxide biosynthetic processCytochrome P450 1B1Homo sapiens (human)
cell adhesionCytochrome P450 1B1Homo sapiens (human)
response to nutrientCytochrome P450 1B1Homo sapiens (human)
steroid metabolic processCytochrome P450 1B1Homo sapiens (human)
estrogen metabolic processCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell population proliferationCytochrome P450 1B1Homo sapiens (human)
male gonad developmentCytochrome P450 1B1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stressCytochrome P450 1B1Homo sapiens (human)
toxin metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionCytochrome P450 1B1Homo sapiens (human)
positive regulation of smooth muscle cell migrationCytochrome P450 1B1Homo sapiens (human)
sterol metabolic processCytochrome P450 1B1Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 1B1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1B1Homo sapiens (human)
collagen fibril organizationCytochrome P450 1B1Homo sapiens (human)
adrenal gland developmentCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell migrationCytochrome P450 1B1Homo sapiens (human)
negative regulation of NF-kappaB transcription factor activityCytochrome P450 1B1Homo sapiens (human)
response to follicle-stimulating hormoneCytochrome P450 1B1Homo sapiens (human)
response to estradiolCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell adhesion mediated by integrinCytochrome P450 1B1Homo sapiens (human)
benzene-containing compound metabolic processCytochrome P450 1B1Homo sapiens (human)
retinol metabolic processCytochrome P450 1B1Homo sapiens (human)
retinal metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of apoptotic processCytochrome P450 1B1Homo sapiens (human)
blood vessel endothelial cell migrationCytochrome P450 1B1Homo sapiens (human)
endothelial cell migrationCytochrome P450 1B1Homo sapiens (human)
estrous cycleCytochrome P450 1B1Homo sapiens (human)
positive regulation of translationCytochrome P450 1B1Homo sapiens (human)
positive regulation of angiogenesisCytochrome P450 1B1Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATCytochrome P450 1B1Homo sapiens (human)
membrane lipid catabolic processCytochrome P450 1B1Homo sapiens (human)
response to arsenic-containing substanceCytochrome P450 1B1Homo sapiens (human)
blood vessel morphogenesisCytochrome P450 1B1Homo sapiens (human)
retinal blood vessel morphogenesisCytochrome P450 1B1Homo sapiens (human)
ganglion developmentCytochrome P450 1B1Homo sapiens (human)
cellular response to hydrogen peroxideCytochrome P450 1B1Homo sapiens (human)
cellular response to cAMPCytochrome P450 1B1Homo sapiens (human)
cellular response to tumor necrosis factorCytochrome P450 1B1Homo sapiens (human)
cellular response to luteinizing hormone stimulusCytochrome P450 1B1Homo sapiens (human)
cellular response to cortisol stimulusCytochrome P450 1B1Homo sapiens (human)
cellular response to progesterone stimulusCytochrome P450 1B1Homo sapiens (human)
response to dexamethasoneCytochrome P450 1B1Homo sapiens (human)
endothelial cell-cell adhesionCytochrome P450 1B1Homo sapiens (human)
response to indole-3-methanolCytochrome P450 1B1Homo sapiens (human)
cellular response to toxic substanceCytochrome P450 1B1Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1B1Homo sapiens (human)
response to 3-methylcholanthreneCytochrome P450 1B1Homo sapiens (human)
regulation of reactive oxygen species metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of DNA biosynthetic processCytochrome P450 1B1Homo sapiens (human)
sulfur amino acid catabolic processThiosulfate sulfurtransferaseHomo sapiens (human)
cyanate catabolic processThiosulfate sulfurtransferaseHomo sapiens (human)
epithelial cell differentiationThiosulfate sulfurtransferaseHomo sapiens (human)
rRNA import into mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
rRNA transportThiosulfate sulfurtransferaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of transcription from RNA polymerase II promoter by glucoseHistone acetyltransferase KAT2BHomo sapiens (human)
gluconeogenesisHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of DNA repairHistone acetyltransferase KAT2BHomo sapiens (human)
chromatin remodelingHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of DNA-templated transcriptionHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
protein acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
heart developmentHistone acetyltransferase KAT2BHomo sapiens (human)
memoryHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of cell population proliferationHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of protein ADP-ribosylationHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of neuron projection developmentHistone acetyltransferase KAT2BHomo sapiens (human)
N-terminal peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
internal peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to insulin stimulusHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to oxidative stressHistone acetyltransferase KAT2BHomo sapiens (human)
vasodilationHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of RNA splicingHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of gluconeogenesisHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of fatty acid biosynthetic processHistone acetyltransferase KAT2BHomo sapiens (human)
transcription initiation-coupled chromatin remodelingHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of glycolytic processHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of DNA-templated transcriptionHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of embryonic developmentHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of centriole replicationHistone acetyltransferase KAT2BHomo sapiens (human)
rhythmic processHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of cell divisionHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of cell cycleHistone acetyltransferase KAT2BHomo sapiens (human)
limb developmentHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to parathyroid hormone stimulusHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of tubulin deacetylationHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of attachment of mitotic spindle microtubules to kinetochoreHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of rRNA processingHistone acetyltransferase KAT2BHomo sapiens (human)
MAPK cascadeMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
immune responseMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
non-canonical NF-kappaB signal transductionMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
defense response to virusMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
cellular response to mechanical stimulusMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
canonical NF-kappaB signal transductionMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (180)

Processvia Protein(s)Taxonomy
magnesium ion bindingDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
MAP kinase activityDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
MAP kinase kinase activityDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
protein tyrosine kinase activityDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
protein bindingDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
ATP bindingDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
JUN kinase kinase activityDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
enzyme bindingDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
protein kinase bindingDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
protein phosphatase bindingDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
protein serine kinase activityDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
molecular function activator activityDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
growth factor bindingReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
RNA polymerase I core bindingReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
protein tyrosine kinase activityReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activityReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
transmembrane signaling receptor activityReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
signaling receptor bindingReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
protein bindingReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
ATP bindingReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
coreceptor activityReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
receptor tyrosine kinase bindingReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
identical protein bindingReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
ErbB-3 class receptor bindingReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
protein heterodimerization activityReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
iron ion bindingCytochrome P450 1A1Homo sapiens (human)
protein bindingCytochrome P450 1A1Homo sapiens (human)
arachidonic acid monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activity, acting on diphenols and related substances as donorsCytochrome P450 1A1Homo sapiens (human)
flavonoid 3'-monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxygen bindingCytochrome P450 1A1Homo sapiens (human)
enzyme bindingCytochrome P450 1A1Homo sapiens (human)
heme bindingCytochrome P450 1A1Homo sapiens (human)
Hsp70 protein bindingCytochrome P450 1A1Homo sapiens (human)
demethylase activityCytochrome P450 1A1Homo sapiens (human)
Hsp90 protein bindingCytochrome P450 1A1Homo sapiens (human)
aromatase activityCytochrome P450 1A1Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
fibroblast growth factor bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-3Homo sapiens (human)
insulin-like growth factor I bindingIntegrin beta-3Homo sapiens (human)
neuregulin bindingIntegrin beta-3Homo sapiens (human)
virus receptor activityIntegrin beta-3Homo sapiens (human)
fibronectin bindingIntegrin beta-3Homo sapiens (human)
protease bindingIntegrin beta-3Homo sapiens (human)
protein disulfide isomerase activityIntegrin beta-3Homo sapiens (human)
protein kinase C bindingIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin beta-3Homo sapiens (human)
integrin bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin beta-3Homo sapiens (human)
coreceptor activityIntegrin beta-3Homo sapiens (human)
enzyme bindingIntegrin beta-3Homo sapiens (human)
identical protein bindingIntegrin beta-3Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin beta-3Homo sapiens (human)
metal ion bindingIntegrin beta-3Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-3Homo sapiens (human)
extracellular matrix bindingIntegrin beta-3Homo sapiens (human)
fibrinogen bindingIntegrin beta-3Homo sapiens (human)
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
protein bindingIntegrin alpha-IIbHomo sapiens (human)
identical protein bindingIntegrin alpha-IIbHomo sapiens (human)
metal ion bindingIntegrin alpha-IIbHomo sapiens (human)
extracellular matrix bindingIntegrin alpha-IIbHomo sapiens (human)
molecular adaptor activityIntegrin alpha-IIbHomo sapiens (human)
fibrinogen bindingIntegrin alpha-IIbHomo sapiens (human)
integrin bindingIntegrin alpha-IIbHomo sapiens (human)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
magnesium ion binding60 kDa chaperoninEscherichia coli K-12
protein binding60 kDa chaperoninEscherichia coli K-12
ATP binding60 kDa chaperoninEscherichia coli K-12
isomerase activity60 kDa chaperoninEscherichia coli K-12
ATP hydrolysis activity60 kDa chaperoninEscherichia coli K-12
identical protein binding60 kDa chaperoninEscherichia coli K-12
unfolded protein binding60 kDa chaperoninEscherichia coli K-12
ATP-dependent protein folding chaperone60 kDa chaperoninEscherichia coli K-12
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K63-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K48-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
monooxygenase activityCytochrome P450 2D6Homo sapiens (human)
iron ion bindingCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activityCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2D6Homo sapiens (human)
heme bindingCytochrome P450 2D6Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
lipopolysaccharide binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
p53 binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
DNA replication origin binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
single-stranded DNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
RNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
double-stranded RNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
high-density lipoprotein particle binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
isomerase activity60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP hydrolysis activity60 kDa heat shock protein, mitochondrialHomo sapiens (human)
enzyme binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ubiquitin protein ligase binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apolipoprotein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apolipoprotein A-I binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
unfolded protein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-folding chaperone binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP-dependent protein folding chaperone60 kDa heat shock protein, mitochondrialHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA bindingDNA topoisomerase 1Homo sapiens (human)
chromatin bindingDNA topoisomerase 1Homo sapiens (human)
double-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
single-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
RNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA topoisomerase type I (single strand cut, ATP-independent) activityDNA topoisomerase 1Homo sapiens (human)
protein serine/threonine kinase activityDNA topoisomerase 1Homo sapiens (human)
protein bindingDNA topoisomerase 1Homo sapiens (human)
ATP bindingDNA topoisomerase 1Homo sapiens (human)
DNA binding, bendingDNA topoisomerase 1Homo sapiens (human)
protein domain specific bindingDNA topoisomerase 1Homo sapiens (human)
supercoiled DNA bindingDNA topoisomerase 1Homo sapiens (human)
monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
iron ion bindingCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 14,15-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 11,12-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C9 Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
aromatase activityCytochrome P450 2C9 Homo sapiens (human)
heme bindingCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C9 Homo sapiens (human)
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
phosphoprotein phosphatase activityM-phase inducer phosphatase 1Homo sapiens (human)
protein tyrosine phosphatase activityM-phase inducer phosphatase 1Homo sapiens (human)
protein bindingM-phase inducer phosphatase 1Homo sapiens (human)
protein kinase bindingM-phase inducer phosphatase 1Homo sapiens (human)
protein-folding chaperone bindingM-phase inducer phosphatase 1Homo sapiens (human)
phosphoprotein phosphatase activityM-phase inducer phosphatase 2Homo sapiens (human)
protein tyrosine phosphatase activityM-phase inducer phosphatase 2Homo sapiens (human)
protein bindingM-phase inducer phosphatase 2Homo sapiens (human)
protein kinase bindingM-phase inducer phosphatase 2Homo sapiens (human)
monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
iron ion bindingCytochrome P450 2C19Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxygen bindingCytochrome P450 2C19Homo sapiens (human)
enzyme bindingCytochrome P450 2C19Homo sapiens (human)
heme bindingCytochrome P450 2C19Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
aromatase activityCytochrome P450 2C19Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C19Homo sapiens (human)
RNA bindingCaspase-7Homo sapiens (human)
aspartic-type endopeptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activityCaspase-7Homo sapiens (human)
protein bindingCaspase-7Homo sapiens (human)
peptidase activityCaspase-7Homo sapiens (human)
cysteine-type peptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in apoptotic processCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in execution phase of apoptosisCaspase-7Homo sapiens (human)
RNA binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding chaperone10 kDa heat shock protein, mitochondrialHomo sapiens (human)
unfolded protein binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-folding chaperone binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
metal ion binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
transcription coregulator bindingHistone acetyltransferase p300Homo sapiens (human)
transcription coactivator bindingHistone acetyltransferase p300Homo sapiens (human)
p53 bindingHistone acetyltransferase p300Homo sapiens (human)
DNA bindingHistone acetyltransferase p300Homo sapiens (human)
chromatin bindingHistone acetyltransferase p300Homo sapiens (human)
damaged DNA bindingHistone acetyltransferase p300Homo sapiens (human)
transcription coactivator activityHistone acetyltransferase p300Homo sapiens (human)
histone acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
lysine N-acetyltransferase activity, acting on acetyl phosphate as donorHistone acetyltransferase p300Homo sapiens (human)
protein bindingHistone acetyltransferase p300Homo sapiens (human)
beta-catenin bindingHistone acetyltransferase p300Homo sapiens (human)
zinc ion bindingHistone acetyltransferase p300Homo sapiens (human)
histone H3 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone H4 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
acyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
nuclear receptor bindingHistone acetyltransferase p300Homo sapiens (human)
peptide N-acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone H3K18 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone H2B acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone H3K27 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
tau protein bindingHistone acetyltransferase p300Homo sapiens (human)
nuclear androgen receptor bindingHistone acetyltransferase p300Homo sapiens (human)
NF-kappaB bindingHistone acetyltransferase p300Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingHistone acetyltransferase p300Homo sapiens (human)
peptide-lysine-N-acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
protein propionyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
pre-mRNA intronic bindingHistone acetyltransferase p300Homo sapiens (human)
STAT family protein bindingHistone acetyltransferase p300Homo sapiens (human)
peptide 2-hydroxyisobutyryltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone lactyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
acetylation-dependent protein bindingHistone acetyltransferase p300Homo sapiens (human)
peptide butyryltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone crotonyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone butyryltransferase activityHistone acetyltransferase p300Homo sapiens (human)
DNA-binding transcription factor bindingHistone acetyltransferase p300Homo sapiens (human)
histone H3K122 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
chromatin DNA bindingHistone acetyltransferase p300Homo sapiens (human)
1-alkyl-2-acetylglycerophosphocholine esterase activityPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
phospholipid bindingPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
hydrolase activity, acting on ester bondsPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
calcium-independent phospholipase A2 activityPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
monooxygenase activityCytochrome P450 1B1Homo sapiens (human)
iron ion bindingCytochrome P450 1B1Homo sapiens (human)
protein bindingCytochrome P450 1B1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1B1Homo sapiens (human)
heme bindingCytochrome P450 1B1Homo sapiens (human)
aromatase activityCytochrome P450 1B1Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1B1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1B1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygenCytochrome P450 1B1Homo sapiens (human)
thiosulfate sulfurtransferase activityThiosulfate sulfurtransferaseHomo sapiens (human)
5S rRNA bindingThiosulfate sulfurtransferaseHomo sapiens (human)
3-mercaptopyruvate sulfurtransferase activityThiosulfate sulfurtransferaseHomo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingHistone acetyltransferase KAT2BHomo sapiens (human)
chromatin bindingHistone acetyltransferase KAT2BHomo sapiens (human)
transcription coregulator activityHistone acetyltransferase KAT2BHomo sapiens (human)
transcription coactivator activityHistone acetyltransferase KAT2BHomo sapiens (human)
diamine N-acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
histone acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
lysine N-acetyltransferase activity, acting on acetyl phosphate as donorHistone acetyltransferase KAT2BHomo sapiens (human)
cyclin-dependent protein serine/threonine kinase inhibitor activityHistone acetyltransferase KAT2BHomo sapiens (human)
protein bindingHistone acetyltransferase KAT2BHomo sapiens (human)
acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
protein kinase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone acetyltransferase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone deacetylase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone H3K9 acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
peptide-lysine-N-acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
DNA-binding transcription factor bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone H3 acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
protein kinase activityMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
protein serine/threonine kinase activityMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
MAP kinase kinase kinase activityMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
protein bindingMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
ATP bindingMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (83)

Processvia Protein(s)Taxonomy
nucleusDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
cytoplasmDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
cytosolDual specificity mitogen-activated protein kinase kinase 7Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
semaphorin receptor complexReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
nucleusReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
nucleoplasmReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
early endosomeReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
cytosolReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
plasma membraneReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
endosome membraneReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
membraneReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
basolateral plasma membraneReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
apical plasma membraneReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
neuromuscular junctionReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
ruffle membraneReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
presynaptic membraneReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
myelin sheathReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
perinuclear region of cytoplasmReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
ERBB3:ERBB2 complexReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
receptor complexReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
plasma membraneReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
basal plasma membraneReceptor tyrosine-protein kinase erbB-2Homo sapiens (human)
mitochondrial inner membraneCytochrome P450 1A1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A1Homo sapiens (human)
glutamatergic synapseIntegrin beta-3Homo sapiens (human)
nucleusIntegrin beta-3Homo sapiens (human)
nucleoplasmIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin beta-3Homo sapiens (human)
cell-cell junctionIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
external side of plasma membraneIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
apical plasma membraneIntegrin beta-3Homo sapiens (human)
platelet alpha granule membraneIntegrin beta-3Homo sapiens (human)
lamellipodium membraneIntegrin beta-3Homo sapiens (human)
filopodium membraneIntegrin beta-3Homo sapiens (human)
microvillus membraneIntegrin beta-3Homo sapiens (human)
ruffle membraneIntegrin beta-3Homo sapiens (human)
integrin alphav-beta3 complexIntegrin beta-3Homo sapiens (human)
melanosomeIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
postsynaptic membraneIntegrin beta-3Homo sapiens (human)
extracellular exosomeIntegrin beta-3Homo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin beta-3Homo sapiens (human)
glycinergic synapseIntegrin beta-3Homo sapiens (human)
integrin complexIntegrin beta-3Homo sapiens (human)
protein-containing complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-HMGB1 complexIntegrin beta-3Homo sapiens (human)
receptor complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin beta-3Homo sapiens (human)
alpha9-beta1 integrin-ADAM8 complexIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
plasma membraneIntegrin alpha-IIbHomo sapiens (human)
focal adhesionIntegrin alpha-IIbHomo sapiens (human)
cell surfaceIntegrin alpha-IIbHomo sapiens (human)
platelet alpha granule membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular exosomeIntegrin alpha-IIbHomo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin alpha-IIbHomo sapiens (human)
blood microparticleIntegrin alpha-IIbHomo sapiens (human)
integrin complexIntegrin alpha-IIbHomo sapiens (human)
external side of plasma membraneIntegrin alpha-IIbHomo sapiens (human)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
cytoplasm60 kDa chaperoninEscherichia coli K-12
cytosol60 kDa chaperoninEscherichia coli K-12
membrane60 kDa chaperoninEscherichia coli K-12
GroEL-GroES complex60 kDa chaperoninEscherichia coli K-12
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mitochondrionCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulumCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2D6Homo sapiens (human)
cytoplasmCytochrome P450 2D6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2D6Homo sapiens (human)
mitochondrial matrix60 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular space60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cytoplasm60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrion60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial inner membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial matrix60 kDa heat shock protein, mitochondrialHomo sapiens (human)
early endosome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cytosol60 kDa heat shock protein, mitochondrialHomo sapiens (human)
plasma membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
clathrin-coated pit60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cell surface60 kDa heat shock protein, mitochondrialHomo sapiens (human)
membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
coated vesicle60 kDa heat shock protein, mitochondrialHomo sapiens (human)
secretory granule60 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular exosome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
sperm midpiece60 kDa heat shock protein, mitochondrialHomo sapiens (human)
sperm plasma membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
migrasome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-containing complex60 kDa heat shock protein, mitochondrialHomo sapiens (human)
lipopolysaccharide receptor complex60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial inner membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
nuclear chromosomeDNA topoisomerase 1Homo sapiens (human)
P-bodyDNA topoisomerase 1Homo sapiens (human)
fibrillar centerDNA topoisomerase 1Homo sapiens (human)
male germ cell nucleusDNA topoisomerase 1Homo sapiens (human)
nucleusDNA topoisomerase 1Homo sapiens (human)
nucleoplasmDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
perikaryonDNA topoisomerase 1Homo sapiens (human)
protein-DNA complexDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C9 Homo sapiens (human)
plasma membraneCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
cytoplasmCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
nucleoplasmM-phase inducer phosphatase 1Homo sapiens (human)
cytosolM-phase inducer phosphatase 1Homo sapiens (human)
nucleusM-phase inducer phosphatase 1Homo sapiens (human)
cytoplasmM-phase inducer phosphatase 1Homo sapiens (human)
spindle poleM-phase inducer phosphatase 2Homo sapiens (human)
nucleoplasmM-phase inducer phosphatase 2Homo sapiens (human)
centrosomeM-phase inducer phosphatase 2Homo sapiens (human)
cytosolM-phase inducer phosphatase 2Homo sapiens (human)
nucleusM-phase inducer phosphatase 2Homo sapiens (human)
cytoplasmM-phase inducer phosphatase 2Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C19Homo sapiens (human)
plasma membraneCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
cytoplasmCytochrome P450 2C19Homo sapiens (human)
extracellular spaceCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
cytoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
nucleoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
mitochondrion10 kDa heat shock protein, mitochondrialHomo sapiens (human)
membrane10 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular exosome10 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial matrix10 kDa heat shock protein, mitochondrialHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
cytoplasmHistone acetyltransferase p300Homo sapiens (human)
cytosolHistone acetyltransferase p300Homo sapiens (human)
nucleusHistone acetyltransferase p300Homo sapiens (human)
nucleoplasmHistone acetyltransferase p300Homo sapiens (human)
cytosolHistone acetyltransferase p300Homo sapiens (human)
chromatinHistone acetyltransferase p300Homo sapiens (human)
protein-DNA complexHistone acetyltransferase p300Homo sapiens (human)
transcription regulator complexHistone acetyltransferase p300Homo sapiens (human)
histone acetyltransferase complexHistone acetyltransferase p300Homo sapiens (human)
extracellular regionPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
low-density lipoprotein particlePlatelet-activating factor acetylhydrolaseHomo sapiens (human)
high-density lipoprotein particlePlatelet-activating factor acetylhydrolaseHomo sapiens (human)
mitochondrionCytochrome P450 1B1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1B1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1B1Homo sapiens (human)
extracellular spaceThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrial matrixThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
SAGA complexHistone acetyltransferase KAT2BHomo sapiens (human)
kinetochoreHistone acetyltransferase KAT2BHomo sapiens (human)
nucleusHistone acetyltransferase KAT2BHomo sapiens (human)
nucleoplasmHistone acetyltransferase KAT2BHomo sapiens (human)
centrosomeHistone acetyltransferase KAT2BHomo sapiens (human)
cytosolHistone acetyltransferase KAT2BHomo sapiens (human)
A bandHistone acetyltransferase KAT2BHomo sapiens (human)
I bandHistone acetyltransferase KAT2BHomo sapiens (human)
actomyosinHistone acetyltransferase KAT2BHomo sapiens (human)
mitotic spindleHistone acetyltransferase KAT2BHomo sapiens (human)
ATAC complexHistone acetyltransferase KAT2BHomo sapiens (human)
protein-containing complexHistone acetyltransferase KAT2BHomo sapiens (human)
fibrillar centerMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
nucleoplasmMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
cytosolMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
intracellular membrane-bounded organelleMitogen-activated protein kinase kinase kinase 14Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (361)

Assay IDTitleYearJournalArticle
AID1411739Inhibition of human recombinant CYP1A1 expressed in HEK293 cells using 7-ethoxyresorufin substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins by fluorescence assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID1157219Inhibition of proto-oncogene protein Wnt/beta-catenin in human SW620 cells assessed as downregulation of TCF/LEF promoter transcriptional activity after 24 hrs by TOPFlash luciferase reporter gene assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1758986Cytotoxicity against human HeLa cells2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.
AID212726Ratio of cytochrome c reduction and NADH oxidation by TcLipDH (Trypanosoma cruzi lipoamide dehydrogenase) at 50 uM concentration, in cytochrome c assay2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID1359899Cytotoxicity against human HCT116 cells assessed as growth inhibition after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jun-25, Volume: 154Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations.
AID751151Antiinflammatory activity in C57-B16/J mouse acute DSS-induced ulcerative colitis model assessed as reversal of body weight loss at 6 to 10 mg/kg administered on day 6 measured up to day 122013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID1359903Induction of reactive oxygen species formation in human A549 cells at 5 uM after 24 hrs by DCFH-DA probe-based flow cytometric analysis relative to control2018European journal of medicinal chemistry, Jun-25, Volume: 154Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations.
AID1359890Cytotoxicity against human HepG2 cells assessed as growth inhibition at 10 uM after 48 hrs by MTT assay relative to control2018European journal of medicinal chemistry, Jun-25, Volume: 154Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations.
AID356966Antibacterial activity against vancomycin-resistant Enterococcus faecalis CKU-17 expressing VanB after 24 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID1517768Cytotoxicity against human MONO-MAC-6 cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent cell viability assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID152094In vitro antimalarial activity against human malaria parasite, P falciparum (Vietnam Smith strain)1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Synthesis and antimalarial activity of 2-aziridinyl- and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives.
AID1157229Inhibition of proto-oncogene protein Wnt in human SW480 cells assessed as downregulation of TCF7L2 protein expression at 6 to 10 uM after 24 hrs by Western blot analysis2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID696891Induction of eryptosis in human erythrocytes assessed as increase in cytosolic Ca2+ up to 2 uM after 48 hrs by Fluo-3/AM-based FACS analysis2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
AID751149Antiinflammatory activity in C57-B16/J mouse DSS-induced ulcerative colitis model assessed as reduction of inflammatory CD14+/CD16+ level in peripheral blood at 6 to 10 mg/kg by flow cytometric analysis relative to DSS-treated control2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID696887Induction of eryptosis in human erythrocytes assessed as phosphatidylserine exposure at 1 uM after 48 hrs by annexin V staining-based FACS analysis2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
AID1326315Inhibition of Bacillus subtilis FtsZ polymerization expressed in Escherichia coli BL21(DE3) pLysS at 10 uM preincubated for 15 mins followed by GTP addition by spectrofluorometric analysis relative to control2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID670011Induction of apoptosis in Her2-overexpressing human SKBR3 cells assessed as increase in Bax protein level after 24 hrs by Western blot analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID696889Hemolysis in human erythrocytes assessed as release of hemoglobin up to 2 uM after 48 hrs by spectrophotometry2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
AID1359887Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition at 10 uM after 48 hrs by MTT assay relative to control2018European journal of medicinal chemistry, Jun-25, Volume: 154Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations.
AID670008Induction of apoptosis in Her2-overexpressing human SKBR3 cells assessed as decrease in Bcl-2 protein level after 24 hrs by Western blot analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID751147Antiinflammatory activity in C57-B16/J mouse DSS-induced ulcerative colitis model assessed as reduction of inflammatory CD14+/CD16+ level in peripheral blood at 8 to 10 mg/kg by flow cytometric analysis relative to DSS-treated control2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID1603001Inhibition of ERK1/2 in paclitaxel-resistant human MCF7/PTX cells assessed as reduction in paclitaxel-induced phosphorylation of ERK1/2 at Thr202/Tyr204 residues up to 3 uM preincubated for 1 hrs followed by 1 nM paclitaxel addition and measured after 30 2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID763580Cytotoxicity against human DU145 cells assessed as growth inhibition after 72 hrs by MTS assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
AID669223Cytotoxicity against Her2-overexpressing human BT474 cells after 24 hrs by MTT assay2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID751141Antiinflammatory activity in C57-B16/J mouse DSS-induced ulcerative colitis model assessed as restoration of goblet cells at 10 mg/kg by hematoxylin-eosin staining-based microscopic analysis2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID1179569Antibacterial activity against methicillin-resistant Staphylococcus aureus at 100 ug/well after 24 hrs by well diffusion assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID669218Induction of cell cycle arrest in Her2-overexpressing human SKBR3 cells assessed as increase in DNA accumulation at subG1 phase after 24 hrs by propidium iodide staining-based flow cytometric analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1091718Antifeedant activity against third instar larvae of Achaea janata in compound treated fresh castor leaves assessed as consumption at 0.1% measured after 6 to 24 hr2009Journal of agricultural and food chemistry, Jul-22, Volume: 57, Issue:14
Synthesis and insect antifeedant activity of plumbagin derivatives with the amino acid moiety.
AID657867Ratio of EC50 for human ACHN cells to EC50 for human ACHN cells in presence of 40 ng/ml TRAIL2012Journal of natural products, Mar-23, Volume: 75, Issue:3
Synergistic TRAIL sensitizers from Barleria alluaudii and Diospyros maritima.
AID1166623Antitubercular activity against Mycobacterium tuberculosis ATCC 27294 in 7H9 medium after 5 days by Alamar blue assay2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Synthesis, characterization, molecular docking and anti-tubercular activity of Plumbagin-Isoniazid Analog and its β-cyclodextrin conjugate.
AID1411735Inhibition of recombinant human CYP3A4 expressed in baker's yeast-derived microsomes (Sacchrosomes) at 10 uM using dibenzylfluorescein substrate by EROD assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID1411733Inhibition of recombinant human CYP1B1 expressed in baker's yeast-derived microsomes (Sacchrosomes) at 10 uM using 7-ethoxyresorufin substrate by EROD assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID1625350Activation of human TRPA1 expressed in HEK293 cells assessed as induction of current at 1 to 10 uM at +70 mV in presence of intracellular catalase by whole cell patch clamp assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID669216Induction of cell cycle arrest in Her2-overexpressing human SKBR3 cells assessed as increase in DNA accumulation at subG1 phase at 5 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis (Rvb = 11%)2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1602991Inhibition of ERK1/2 in human MCF7 cells assessed as reduction in paclitaxel-induced phosphorylation of ERK1/2 at Thr202/Tyr204 residues up to 3 uM preincubated for 1 hrs followed by 1 nM paclitaxel addition and measured after 30 mins by AlphaScreen analy2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1603000Induction of apoptosis in human MCF7 cells at 3 uM after 24 hrs by Annexin V-phycoerythrin/7-AAD staining based flow cytometric analysis relative to control2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID403298Antimicrobial activity against Candida albicans assessed as 99.9 % growth inhibition after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID356961Antibacterial activity against methicillin-resistant Staphylococcus aureus 8-8S after 48 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID1602986Inhibition of ERK1/2 in human BT474 cells assessed as reduction in EGF-induced phosphorylation of ERK1/2 level up to 1 uM preincubated for 24 hrs followed by EGF addition and measured after 30 mins by Western blot analysis2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1517770Cytotoxicity against human SW982 cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent cell viability assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID1602988Inhibition of ERK1/2 in human MCF7 cells assessed as reduction in EGF-induced phosphorylation of ERK1/2 at Thr202/Tyr204 residues up to 3 uM preincubated for 1 hrs followed by EGF addition and measured after 30 mins by AlphaScreen analysis relative to con2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1156517Cytotoxicity against human MCF7 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID669225Antitumor activity against human MDA-MB-231 cells xenografted in nude mouse assessed as decrease in tumor volume2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1755841Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID1444788Inhibition of osteopontin-induced FAK phosphorylation in human A549 cells at 1 to 2 uM after 15 mins by Western blot method2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID1062011Cytotoxicity against human MCF7 cells expressing pcDNA3 assessed as reduction of cell viability at 10 uM after 48 hrs CellTiter-Glo assay2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
AID1444786Inhibition of FAK/AKT/ROCK in human A549 cells assessed as reduction in osteopontin-induced cofilin phosphorylation after 24 hrs by Western blot method2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID492425Antimalarial activity against Plasmodium falciparum2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Antimalarials from nature.
AID356963Antibacterial activity against Enterococcus faecalis after 48 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID1444785Inhibition of FAK/AKT/ROCK in human A549 cells assessed as reduction in osteopontin-induced LIMK1/2 phosphorylation after 24 hrs by Western blot method2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID1157223Inhibition of proto-oncogene protein Wnt in human SW620 cells assessed as downregulation of beta-catenin protein expression at 6 uM after 24 hrs by Western blot analysis2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1625339Activation of human TRPA1 expressed in HEK293 cells assessed as increase in calcium level by fluo-4 dye based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID751145Antiinflammatory activity in C57-B16/J mouse chronic DSS-induced ulcerative colitis model assessed as decrease in serum IFNgamma level at 10 mg/kg administered for total of 3 weeks for alternative weeks with water measured after 63 days by ELISA relative 2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID1594139Inhibition of human N-terminal octa-His-tagged HSP60 expressed in Escherichia coli Rosetta(DE3) pLysS/human HSP10 expressed in Escherichia coli Rosetta(DE3) assessed as reduction in HSP60/HSP10-mediated denatured MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID669220Anticlonogenic activity in Her2-overexpressing human BT474 cells assessed as inhibition of colony formation at 1 uM after 6 hrs followed by washout measured after 16 days by crystal violet staining2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1062001Inhibition of EGFR autophosphorylation at Y1068 in human MCF7 cells expressing HER2delta16 at 10 uM after 2 hrs by Western blotting2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
AID1326320Antibacterial activity against methicillin-sensitive Staphylococcus aureus after 18 hrs by broth microdilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID657260Antiproliferative activity against ER-negative human MDA-MB-468 cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells.
AID1411740Inhibition of human recombinant CYP1A2 expressed in HEK293 cells using 3-cyano-7-ethoxycoumarin substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins by fluorescence assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID357217Ratio of MBC to MIC for vancomycin-resistant Enterococcus faecalis CKU-17 expressing VanB2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID1282387Inhibition of recombinant His6-tagged p300 catalytic domain (1284 to1673 residues) (unknown origin) expressed in baculovirus expression system using histone substrate after 10 mins by liquid scintillation counting method in presence of [3H]acetyl-CoA2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
AID356962Antibacterial activity against Enterococcus faecalis after 24 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID1166624Antitubercular activity against Mycobacterium tuberculosis ATCC 27294 in high iron condition after 5 days by Alamar blue assay2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Synthesis, characterization, molecular docking and anti-tubercular activity of Plumbagin-Isoniazid Analog and its β-cyclodextrin conjugate.
AID356959Antibacterial activity against Staphylococcus aureus after 48 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID696885Hemolysis in human erythrocytes assessed as release of hemoglobin at 1 uM after 48 hrs by spectrophotometry2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
AID1607730Displacement of [3H]-acetyl-CoA from recombinant PCAF (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by substrate addition measured after 10 mins2019European journal of medicinal chemistry, Sep-15, Volume: 178Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism.
AID103793The second order rate constant of the pig heart LipDH (lipoamide dehydrogenase) catalyzed NADH oxidation. 2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID1062007Inhibition of HER2 (unknown origin) by ADP-Glo assay2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
AID1411745Inhibition of human recombinant CYP3A4 expressed in HEK293 cells using dibenzylfluorescein substrate substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins by fluorescence assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID1625347Activation of human TRPA1 expressed in HEK293 cells assessed as induction of current at 1 uM at -70 to +70 mV by whole cell patch clamp assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID751150Oral bioavailability in rat2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID751142Antiinflammatory activity in C57-B16/J mouse chronic DSS-induced ulcerative colitis model assessed as suppression of clinical symptoms at 8 to 10 mg/kg administered for total of 3 weeks for alternative weeks with water measured after 63 days2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID1625337Activation of human TRPA1 expressed in HEK293 cells assessed as increase in calcium level at 20 uM in presence of TRPA1 channel blocker A-967079 by fura2/AM dye based single cell based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1157235Cytotoxicity against p53-deficient human HCT116 cells assessed as cell viability after 24 hrs by MTT assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1411737Inhibition of recombinant human CYP2C19 expressed in baker's yeast-derived microsomes (Sacchrosomes) at 10 uM using 3-cyano-7-ethoxycoumarin substrate by EROD assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID1157215Cytotoxicity against human SW480 cells assessed as cell viability after 24 hrs by MTT assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID103796Ratio of cytochrome c reduction and NADH oxidation by pig heart LipDH (lipoamide dehydrogenase) at 50 uM concentration, in cytochrome c assay2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID1062005Inhibition of HER2 autophosphorylation at Y1248 in human MCF7 cells at 10 uM after 2 hrs by Western blotting2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
AID1157220Inhibition of proto-oncogene protein Wnt/beta-catenin in human SW620 cells assessed as downregulation of mutant TCF/LEF promoter transcriptional activity at 1 to 3 uM after 24 hrs by FOPFlash luciferase reporter gene assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID493445Inhibition of human recombinant GST-fused NIK expressed in Sf9 cells after 60 mins by radiometric protein kinase assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
NF-kappaB inducing kinase (NIK) inhibitors: identification of new scaffolds using virtual screening.
AID1782670Inhibition of human CRM1-C528S mutant assessed as C528 conjugation at 20 uM incubated for 2 hrs before binding by coomassie blue staining based pull-down assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Novel Mechanistic Observations and NES-Binding Groove Features Revealed by the CRM1 Inhibitors Plumbagin and Oridonin.
AID1157242Upregulation of HBP1 protein expression in p53-deficient human HCT116 cells at 10 uM after 24 hrs by Western blot analysis2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1517775Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent cell viability assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID1326316Inhibition of Bacillus subtilis FtsZ GTPase activity expressed in Escherichia coli BL21(DE3) pLysS at 24 uM preincubated for 15 mins followed by GTP addition after 10 mins by malachite green ammonium molybdate assay relative to control2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID1397258Cytotoxicity against human WI38 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Anti-acute myeloid leukemia activity of 2-chloro-3-alkyl-1,4-naphthoquinone derivatives through inducing mtDNA damage and GSH depletion.
AID1782669Inhibition of human wild type CRM1 assessed as C528 conjugation at 20 uM incubated for 2 hrs before binding by coomassie blue staining based pull-down assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Novel Mechanistic Observations and NES-Binding Groove Features Revealed by the CRM1 Inhibitors Plumbagin and Oridonin.
AID1271955Growth inhibition of human A549 cells by MTT assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID669212Induction of apoptosis in Her2-overexpressing human SKBR3 cells assessed as increase in caspase activity after 6 hrs by fluorescence analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1594140Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID763579Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by MTS assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
AID1157227Inhibition of proto-oncogene protein Wnt in human SW480 cells assessed as downregulation of beta-catenin protein expression at 6 to 10 uM after 24 hrs by Western blot analysis2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1602996Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 24 hrs by MTT assay2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1156521Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID1758985Cytotoxicity against human KB cells2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.
AID660831Cytotoxicity against human ACHN cells assessed as cell death after 20 to 24 hrs by XTT assay2012Journal of natural products, Mar-23, Volume: 75, Issue:3
Synergistic TRAIL sensitizers from Barleria alluaudii and Diospyros maritima.
AID403267Cytotoxicity against human KB cells2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID403268Cytotoxicity against human Lu1 cells2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID751152Antiinflammatory activity in C57-B16/J mouse acute DSS-induced ulcerative colitis model assessed as suppression of clinical symptoms at 8 to 10 mg/kg administered on day 6 measured up to day 122013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID1359901Cytotoxicity against human WRL68 cells assessed as growth inhibition after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jun-25, Volume: 154Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations.
AID1062002Inhibition of EGFR autophosphorylation at Y1068 in human MCF7 cells expressing HER2 at 10 uM after 2 hrs by Western blotting2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
AID356967Antibacterial activity against vancomycin-resistant Enterococcus faecalis CKU-17 expressing VanB after 48 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID357214Ratio of MBC to MIC for methicillin-resistant Staphylococcus aureus 8-8S2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID669209Induction of apoptosis in Her2-overexpressing human BT474 cells assessed as increase in Bax protein level after 24 hrs by Western blot analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1156516Cytotoxicity against human ME180 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID212732Vmax is the maximum velocity of the TcTR (Trypanosoma cruzi trypanothione reductase) catalyzed NADH oxidation. 2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID1444787Effect on total LIMK2 expression level in human A549 cells at 1 to 2 uM after 24 hrs by Western blot method2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID1811678Binding affinity to Bacillus subtilis FtsZ assessed as decrease in fluorescence anisotropy values at 20 to 200 uM by fluorescence anisotropy analysis2021Journal of medicinal chemistry, 05-13, Volume: 64, Issue:9
Targeting the FtsZ Allosteric Binding Site with a Novel Fluorescence Polarization Screen, Cytological and Structural Approaches for Antibacterial Discovery.
AID696886Induction of eryptosis in human erythrocytes assessed as phosphatidylserine exposure up to 2 uM after 48 hrs by annexin V staining-based FACS analysis2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
AID1444781Effect on total AKT expression level in human A549 cells at 1 to 2 uM after 15 mins by Western blot method2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID228426Inhibition of topoisomerase I1998Bioorganic & medicinal chemistry letters, Dec-01, Volume: 8, Issue:23
Inhibition of topoisomerase I by naphthoquinone derivatives.
AID1091723Toxicity in third-instar larvae of tobacco caterpillar Spodoptera litura assessed as mortality at 4 ug/insect measured after 4 to 28 days by topical bioassay2009Journal of agricultural and food chemistry, Jul-22, Volume: 57, Issue:14
Synthesis and insect antifeedant activity of plumbagin derivatives with the amino acid moiety.
AID751137Antiinflammatory activity in C57-B16/J mouse chronic DSS-induced ulcerative colitis model assessed as restoration of colon size at 6 to 10 mg/kg administered for total of 3 weeks for alternative weeks with water measured after 63 days2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID1602993Inhibition of ERK1/2 in human MDA-MB-468 cells assessed as reduction in paclitaxel-induced phosphorylation of ERK1/2 at Thr202/Tyr204 residues up to 1 uM preincubated for 1 hrs followed by 1 nM paclitaxel addition and measured after 30 mins by AlphaScreen2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1594137Inhibition of ATPase activity of Escherichia coli GroEL expressed in Escherichia coliDH5alpha incubated for 60 mins using ATP by spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1271958Growth inhibition of mouse B16F10 cells by MTT assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID1491237Drug degradation in PBS at pH 7.4 at 1000 uM after 24 hrs by HPLC method2017European journal of medicinal chemistry, Sep-08, Volume: 137Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
AID1517773Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent cell viability assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID1517765Inhibition of recombinant Cdc25B (unknown origin) using OMFP as substrate measured every 30 sec for 10 mins by fluorometric assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID1517790Inhibition of recombinant HNE (unknown origin) at <50 uM using N-methylsuccinyl-Ala-Ala-Pro-Val-7-amino-4-methylcoumarin, as a substrate measured every 30 sec for 10 mins by fluorometric assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID1602983Induction of apoptosis in human MDA-MB-468 cells at 0.2 uM after 24 hrs in presence of 1 nM of paclitaxel by Annexin V-phycoerythrin/7-AAD staining based flow cytometric analysis relative to control2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1491236Chemical stability in PBS at pH 6 at 1000 uM after 3 to 24 hrs by HPLC method2017European journal of medicinal chemistry, Sep-08, Volume: 137Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
AID1602975Synergistic cytotoxicity against human BT474 cells assessed as combination index at 1 to 5 uM after 24 hrs in presence of 0.1 to 20 nM of paclitaxel by MTT assay2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID669214Induction of apoptosis in Her2-overexpressing human BT474 cells assessed as accumulation at subG1 phase by propidium iodide staining-based flow cytometric analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1602976Synergistic cytotoxicity against human MCF7 cells assessed as combination index at 1 to 5 uM after 24 hrs in presence of 0.5 to 10 nM of paclitaxel by MTT assay2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1359900Cytotoxicity against human HK2 cells assessed as growth inhibition after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jun-25, Volume: 154Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations.
AID1444783Effect on total cofilin protein expression level in human A549 cells at 1 to 2 uM after 24 hrs by Western blot method2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1179570Antibacterial activity against Pseudomonas aeruginosa MTCC 201 at 100 ug/well after 24 hrs by well diffusion assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID1625349Activation of human TRPA1 expressed in HEK293 cells assessed as induction of current at 1 to 10 uM at +70 mV in presence of extracellular catalase by whole cell patch clamp assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1271954Growth inhibition of human Hs683 cells by MTT assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID1157233Inhibition of proto-oncogene protein Wnt/beta-catenin in human SW620 cells assessed as downregulation of vimentin protein expression at 6 uM after 24 hrs by Western blot analysis relative to control2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID657261Antiproliferative activity against ER-positive human MCF7 cells after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells.
AID1326319Antibacterial activity against Klebsiella pneumoniae ATCC BAA-1144 after 18 hrs by broth microdilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID56357Concentration required for inhibition of human homologous Disulphide oxidoreductase (hGR)2000Bioorganic & medicinal chemistry letters, Apr-03, Volume: 10, Issue:7
Parallel synthesis of a library of 1,4-naphthoquinones and automated screening of potential inhibitors of trypanothione reductase from Trypanosoma cruzi.
AID1761903Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth at < 0.2 ug/ml incubated for 18 hrs by resazurin dye based assay2021Journal of natural products, 04-23, Volume: 84, Issue:4
Phytochemical Profiling and Biological Activity of the Australian Carnivorous Plant,
AID696882Stimulation of ceramide formation in human erythrocytes at 2 uM after 48 hrs by FITC-labeled anticeramide antibody method2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
AID1157234Cytotoxicity against human HCT116 cells expressing p53 assessed as cell viability after 24 hrs by MTT assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1602985Inhibition of ERK1/2 in human MCF7 cells assessed as reduction in EGF-induced phosphorylation of ERK1/2 level up to 1 uM preincubated for 24 hrs followed by EGF addition and measured after 30 mins by Western blot analysis2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID403283Antifungal activity against Saccharomyces cerevisiae assessed as 99.9 % growth inhibition after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1517763Inhibition of recombinant Cdc25A (unknown origin) using OMFP as substrate measured every 30 sec for 10 mins by fluorometric assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID403279Antifungal activity against Candida albicans after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID212731The Michaelis-Menten constant for NADPH oxidation by TcTR (Trypanosoma cruzi trypanothione reductase)2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID96103Compound dose toxic against macrophages of Leishmania donovani (100 % inhibition)2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID1091725Antifeedant activity against third-instar larvae of tobacco caterpillar Spodoptera litura in compound treated fresh castor leaves assessed as consumption at 28 +/- 2 degC, relative humidity 65 +/- 5 measured after 6 to 24 hr2009Journal of agricultural and food chemistry, Jul-22, Volume: 57, Issue:14
Synthesis and insect antifeedant activity of plumbagin derivatives with the amino acid moiety.
AID1062006Inhibition of HER2 autophosphorylation at Y1248 in human MCF7 cells expressing pcDNA3 at 10 uM after 2 hrs by Western blotting2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
AID1758987Redox potential of compound in phosphate buffer at pH 7.2 by cyclic voltammetry2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.
AID1444778Inhibition of FAK/AKT/ROCK in human A549 cells assessed as reduction in osteopontin-induced cell invasion at 1 uM preincubated for 30 mins followed by osteopontin addition measured after 24 hrs by Diff-quick staining based matrigel-mediated Boyden chamber2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID1444779Effect on total FAK expression levels in human A549 cells at 1 to 2 uM measured after 15 mins by Western blot method2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID403282Antifungal activity against Saccharomyces cerevisiae after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1517776Cytotoxicity against human PBMC cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent cell viability assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID660832Cytotoxicity against human ACHN cells assessed as cell death after 20 to 24 hrs by XTT assay in presence of 40 ng/ml TRAIL2012Journal of natural products, Mar-23, Volume: 75, Issue:3
Synergistic TRAIL sensitizers from Barleria alluaudii and Diospyros maritima.
AID1517767Cytotoxicity against human THP1 cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent cell viability assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID403284Antifungal activity against Aspergillus niger after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1359898Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jun-25, Volume: 154Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations.
AID1411734Inhibition of recombinant human CYP2D6 expressed in baker's yeast-derived microsomes (Sacchrosomes) at 10 uM using 7-ethoxy-methyloxy-3-cyanocoumarin substrate by EROD assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID1062003Inhibition of EGFR autophosphorylation at Y1068 in human MCF7 cells expressing pcDNA3 at 10 uM after 2 hrs by Western blotting2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
AID1602999Induction of apoptosis in paclitaxel-resistant human MCF7/PTX cells at 3 uM after 24 hrs by Annexin V-phycoerythrin/7-AAD staining based flow cytometric analysis relative to control2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1271959Growth inhibition of human U373 cells by MTT assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID1062010Cytotoxicity against human MCF7 cells expressing pcDNA3 assessed as reduction of cell viability after 48 hrs CellTiter-Glo assay2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
AID1602981Induction of apoptosis in human BT474 cells up to 2.5 uM after 24 hrs in presence of 2 nM of paclitaxel by Annexin V-phycoerythrin/7-AAD staining based flow cytometric analysis relative to control2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID403274Antimicrobial activity against Staphylococcus aureus assessed as 99.9 % growth inhibition after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID696892Induction of eryptosis in human erythrocytes assessed as reduction in cell volume measuring forward scatter at 1.5 uM after 48 hrs by FACS analysis2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
AID1594144Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID669217Induction of cell cycle arrest in Her2-overexpressing human SKBR3 cells assessed as increase in DNA accumulation at subG1 phase at 2.5 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis (Rvb = 11%)2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID751138Antiinflammatory activity in C57-B16/J mouse DSS-induced ulcerative colitis model assessed as reduction in monocyte aggregation at 10 mg/kg by hematoxylin-eosin staining-based microscopic analysis2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID1517772Cytotoxicity against human U937 cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent cell viability assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID409958Inhibition of bovine brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID1157232Inhibition of proto-oncogene protein Wnt/beta-catenin in human SW620 cells assessed as downregulation of cyclin D1 protein expression at 6 uM after 24 hrs by Western blot analysis relative to control2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1179572Antibacterial activity against methicillin-resistant Staphylococcus aureus by NCCLS method2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID1594135Inhibition of native rhodanese (unknown origin) assessed as reduction in rhodanese enzyme activity after 45 mins by Fe(SCN)3 dye based spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID403273Antimicrobial activity against Staphylococcus aureus after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1326313Inhibition of Bacillus subtilis FtsZ polymerization expressed in Escherichia coli BL21(DE3) pLysS at 2 uM preincubated for 15 mins followed by GTP addition by spectrofluorometric analysis relative to control2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID1761904Antimicrobial activity against Cryptococcus neoformans var. grubii ATCC 208821 assessed as inhibition of fungal growth at 8 ug/ml incubated for 24 hrs by resazurin dye based assay2021Journal of natural products, 04-23, Volume: 84, Issue:4
Phytochemical Profiling and Biological Activity of the Australian Carnivorous Plant,
AID1491223Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition at 10 uM after 72 hrs by MTT assay relative to control2017European journal of medicinal chemistry, Sep-08, Volume: 137Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
AID1156519Cytotoxicity against human MDA-MB-453 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID1602994Induction of apoptosis in human MDA-MB-468 cells pre-treated with ERK1/2 siRNA at 0.2 uM in presence of 1 nM paclitaxel by Annexin V-phycoerythrin/7-AAD staining based flow cytometric analysis relative to control2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID479263Larvicidal activity against Aedes aegypti fourth instar larvae after 24 hrs2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Bioactivity-guided isolation of mosquitocidal constituents from the rhizomes of Plumbago capensis Thunb.
AID1602987Inhibition of ERK1/2 in human MDA-MB-468 cells assessed as reduction in EGF-induced phosphorylation of ERK1/2 level up to 0.5 uM preincubated for 24 hrs followed by EGF addition and measured after 30 mins by Western blot analysis2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID357215Ratio of MBC to MIC for Enterococcus faecalis2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID1271957Growth inhibition of human SK-MEL-28 cells by MTT assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID1157226Inhibition of proto-oncogene protein Wnt in human SW620 cells assessed as downregulation of Bcl9l protein expression at 6 uM after 24 hrs by Western blot analysis2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1444789Inhibition of osteopontin-induced AKT phosphorylation in human A549 cells at 1 to 2 uM after 15 mins by Western blot method2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID751139Antiinflammatory activity in C57-B16/J mouse DSS-induced ulcerative colitis model assessed as restoration of submucosa at 10 mg/kg by hematoxylin-eosin staining-based microscopic analysis2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1491233Selectivity ratio of IC50 for human A549 cells to IC50 for human MDA-MB-231 cells2017European journal of medicinal chemistry, Sep-08, Volume: 137Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
AID356965Antibacterial activity against vancomycin-resistant Enterococcus faecium F935 expressing VanA after 48 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID403281Antifungal activity against Cryptococcus neoformans assessed as 99.9 % growth inhibition after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1359896Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jun-25, Volume: 154Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations.
AID1282388Inhibition of recombinant PCAF (unknown origin) expressed in baculovirus expression system using histone substrate after 10 mins by liquid scintillation counting method in presence of [3H]acetyl-CoA2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
AID1157222Inhibition of proto-oncogene protein Wnt/beta-catenin in human SW480 cells assessed as downregulation of mutant TCF/LEF promoter transcriptional activity at 1 to 3 uM after 24 hrs by FOPFlash luciferase reporter gene assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID669224Cytotoxicity against Her2-overexpressing human SKBR3 cells after 24 hrs by MTT assay2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1444791Anticancer activity against human A549 cells xenografted in BalB/c nude mouse assessed as reduction in osteopontin-induced lung metastasis at 5 mg/kg, ip administered once daily for 8 weeks by India ink staining based method2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID208362Compound dose toxic against macrophages of Trypanosoma cruzi (100 % inhibition)2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID1359888Cytotoxicity against human A549 cells assessed as growth inhibition at 10 uM after 48 hrs by MTT assay relative to control2018European journal of medicinal chemistry, Jun-25, Volume: 154Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations.
AID1491230Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay2017European journal of medicinal chemistry, Sep-08, Volume: 137Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
AID1625351Activation of TRPA1 in wild type mouse DRG neurons assessed as increase in calcium level at 10 uM by fura2/AM dye based plate reader analysis relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1491240Drug degradation in PBS at pH 8 at 1000 uM after 24 hrs by HPLC method2017European journal of medicinal chemistry, Sep-08, Volume: 137Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
AID657259Inhibition of NFkappaB p65 subunit expression in human MDA-MB-231 cells at 1.5 uM after 48 hrs by Western blot analysis2012Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells.
AID1411732Inhibition of recombinant human CYP1A2 expressed in baker's yeast-derived microsomes (Sacchrosomes) at 10 uM using 3-cyano-7-ethoxycoumarin substrate by EROD assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID1444772Cytotoxicity against human A549 cells after 24 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID1157240Upregulation of HBP1 protein expression in human SW620 cells at 6 uM after 24 hrs by Western blot analysis relative to control2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1594134Inhibition of native soluble pig heart MDH assessed as reduction in MDH enzyme activity using sodium mesoxalate as substrate and NADH by malachite green dye based spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1062013Cytotoxicity against human MCF7 cells expressing HER2 assessed as reduction of cell viability at 10 uM after 48 hrs CellTiter-Glo assay2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
AID1091722Toxicity in third instar larvae of Achaea janata assessed as mortality at 4 ug/insect measured after 4 to 28 days by topical bioassay2009Journal of agricultural and food chemistry, Jul-22, Volume: 57, Issue:14
Synthesis and insect antifeedant activity of plumbagin derivatives with the amino acid moiety.
AID669226Ratio of IC50 for Her2-overexpressing human BT474 cells after 24 hrs to IC50 for Her2-overexpressing human BT474 cells after 72 hrs2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID696888Induction of eryptosis in human erythrocytes assessed as reduction in cell volume measuring forward scatter up to 2 uM after 48 hrs by FACS analysis2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
AID1153363Cytotoxicity against human MCF7 cells expressing estrogen and progesterone receptor after 72 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Jul-01, Volume: 24, Issue:13
Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
AID1157217Cytotoxicity against human SW620 cells assessed as cell viability after 24 hrs by MTT assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID403270Cytotoxicity against human HUVEC2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1602984Induction of apoptosis in human MDA-MB-468 cells at 0.5 uM after 24 hrs in presence of 1 nM of paclitaxel by Annexin V-phycoerythrin/7-AAD staining based flow cytometric analysis relative to control2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID212596Vmax is the maximum velocity of the TcLipDH (Trypanosoma cruzi lipoamide dehydrogenase) catalyzed NADH oxidation2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID1411743Inhibition of human recombinant CYP2C9 expressed in HEK293 cells using 3-cyano-7-ethoxycoumarin substrate substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins by fluorescence assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID1444776Inhibition of FAK/AKT/ROCK in human H1299 cells assessed as reduction in osteopontin-induced cell motility at 1 to 2 uM preincubated for 30 mins followed by osteopontin addition measured after 24 hrs by Diff-quick staining based matrigel-mediated Boyden c2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID1397256Cytotoxicity against human HL60 cells after 24 hrs by MTT assay2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Anti-acute myeloid leukemia activity of 2-chloro-3-alkyl-1,4-naphthoquinone derivatives through inducing mtDNA damage and GSH depletion.
AID696884Induction of eryptosis in human erythrocytes assessed as cell membrane scrambling at 1 uM after 48 hrs by annexin V staining-based FACS analysis in presence of extracellular Ca2+2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
AID1491229Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by MTT assay2017European journal of medicinal chemistry, Sep-08, Volume: 137Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
AID1157224Inhibition of proto-oncogene protein Wnt in human SW620 cells assessed as downregulation of p300 protein expression at 6 uM after 24 hrs by Western blot analysis2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1444774Inhibition of FAK/AKT/ROCK in human A549 cells assessed as reduction in osteopontin-induced cell motility at 1 uM preincubated for 30 mins followed by osteopontin addition measured after 24 hrs by Diff-quick staining based matrigel-mediated Boyden chamber2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID403287Toxicity in human LNCaP cell xenografted mouse assessed as body weight loss at 5 mg/kg2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1062004Inhibition of HER2 delta16 mutant autophosphorylation at Y1248 in human MCF7 cells at 10 uM after 2 hrs by Western blotting2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
AID1607729Displacement of [3H]-acetyl-CoA from recombinant P300 (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by substrate addition measured after 10 mins2019European journal of medicinal chemistry, Sep-15, Volume: 178Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism.
AID403286Toxicity in human KB cell xenografted mouse assessed as body weight loss at 5 mg/kg2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1602992Inhibition of ERK1/2 in human BT474 cells assessed as reduction in paclitaxel-induced phosphorylation of ERK1/2 at Thr202/Tyr204 residues up to 2 uM preincubated for 1 hrs followed by 1 nM paclitaxel addition and measured after 30 mins by AlphaScreen anal2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1603002Potentiation of paclitaxel-induced apoptosis in paclitaxel-resistant human MCF7/PTX cells at 2 uM after 24 hrs by Annexin V-phycoerythrin/7-AAD staining based flow cytometric analysis2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1517771Cytotoxicity against human Jurkat cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent cell viability assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID763573Binding affinity to STAT3 SH2 domain (unknown origin) using 5-FAM-SpYLPQTV as probe assessed as inhibition of protein dimerization at 500 uM after 60 mins by fluorescence polarization assay relative to control2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
AID1411738Inhibition of human recombinant CYP1A1 expressed in HEK293 cells at 10 uM using 7-ethoxyresorufin substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins by fluorescence assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID103795Vmax is the maximum velocity of the pig heart LipDH (lipoamide dehydrogenase) catalyzed NADH oxidation2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID356960Antibacterial activity against methicillin-resistant Staphylococcus aureus 8-8S after 24 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID696890Induction of eryptosis in human erythrocytes assessed as increase in cytosolic Ca2+ at 0.5 uM after 48 hrs by Fluo-3/AM-based FACS analysis2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
AID1782668Inhibition of Yeast GST-tagged/TEV cleavage site fused CRM1 C152/C539/D1034A triple mutant expressed in Escherichia coli BL21 (DE3) assessed as decrease in NES binding at 60 uM measured after 2 hrs by coomassie blue staining based pull-down assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Novel Mechanistic Observations and NES-Binding Groove Features Revealed by the CRM1 Inhibitors Plumbagin and Oridonin.
AID403285Antifungal activity against Aspergillus niger assessed as 99.9 % growth inhibition after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1761902Cytotoxicity against human HEK293 cells at 32 ug/ml2021Journal of natural products, 04-23, Volume: 84, Issue:4
Phytochemical Profiling and Biological Activity of the Australian Carnivorous Plant,
AID1156518Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID212595The Michaelis-Menten constant for NADPH oxidation by TcLipDH (Trypanosoma cruzi lipoamide dehydrogenase)2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID1326314Inhibition of Bacillus subtilis FtsZ polymerization expressed in Escherichia coli BL21(DE3) pLysS at 5 uM preincubated for 15 mins followed by GTP addition by spectrofluorometric analysis relative to control2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID751148Toxicity in C57-B16/J mouse DSS-induced ulcerative colitis model assessed as circulating CD14+/CD16- level at 6 to 10 mg/kg by flow cytometric analysis relative to DSS-treated control2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID669208Induction of apoptosis in Her2-overexpressing human BT474 cells assessed as increase in BaK protein level after 24 hrs by Western blot analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1602995Induction of apoptosis in human BT474 cells pre-treated with ERK1/2 siRNA at 1.5 uM in presence of 2 nM paclitaxel by Annexin V-phycoerythrin/7-AAD staining based flow cytometric analysis relative to control2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID669211Induction of apoptosis in Her2-overexpressing human BT474 cells assessed as increase in caspase activity at 10 uM after 6 hrs by fluorescence analysis relative to control2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID669219Anticlonogenic activity in Her2-overexpressing human SKBR3 cells assessed as inhibition of colony formation at 1 uM after 6 hrs followed by washout measured after 16 days by crystal violet staining2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID357216Ratio of MBC to MIC for vancomycin-resistant Enterococcus faecium F935 expressing VanA2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID751144Antiinflammatory activity in C57-B16/J mouse chronic DSS-induced ulcerative colitis model assessed as decrease in serum IL-17 level at 8 mg/kg administered for total of 3 weeks for alternative weeks with water measured after 63 days by ELISA relative to D2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID212736Rate of NADPH oxidation by TcTR in presence of 25 uM NQ was determined in comparison to intrinsic oxidase activity2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID212729The second oder rate constant of the TcTR (Trypanosoma cruzi trypanothione reductase) catalyzed NADH oxidation. 2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID1157237Inhibition of proto-oncogene protein Wnt/beta-catenin in p53-deficient human HCT116 cells assessed as downregulation of TCF/LEF promoter transcriptional activity at 5 to 10 uM after 24 hrs by TOPFlash/FOPFlash luciferase reporter gene assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1625352Lipophilicity, logP of compound2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1602982Induction of apoptosis in human MCF7 cells pre-treated with ERK1/2 siRNA at 2 uM in presence of 1 nM paclitaxel by Annexin V-phycoerythrin/7-AAD staining based flow cytometric analysis relative to control2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1607752Inhibition of PCAF in human HeLa cells using [3H]-acetyl-CoA as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins by liquid scintillation counting analysis2019European journal of medicinal chemistry, Sep-15, Volume: 178Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism.
AID763578Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTS assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
AID1411744Inhibition of human recombinant CYP2C19 expressed in HEK293 cells using 3-cyano-7-ethoxycoumarin substrate substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins by fluorescence assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID1062009Cytotoxicity against human MCF7 cells expressing HER2 assessed as reduction of cell viability after 48 hrs CellTiter-Glo assay2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
AID1517769Cytotoxicity against human HL60 cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent cell viability assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID379656Larvicidal activity against Aedes aegypti assessed as drug level required to kill instar II larvae after 24 hrs2000Journal of natural products, Mar, Volume: 63, Issue:3
Antifungal and larvicidal compounds from the root bark of Cordia alliodora.
AID1157228Inhibition of proto-oncogene protein Wnt in human SW480 cells assessed as downregulation of p300 protein expression at 6 to 10 uM after 24 hrs by Western blot analysis2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1491231Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay2017European journal of medicinal chemistry, Sep-08, Volume: 137Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
AID1359897Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay2018European journal of medicinal chemistry, Jun-25, Volume: 154Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations.
AID208238In vitro antiparasitic activity against Trypanosoma cruzi was tested by sigmoidal regression analysis; at 10 uM value is T/1002001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID403269Cytotoxicity against human LNCAP cells2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID493444Inhibition of human recombinant GST-fused NIK expressed in Sf9 cells at 50 uM after 60 mins by radiometric protein kinase assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
NF-kappaB inducing kinase (NIK) inhibitors: identification of new scaffolds using virtual screening.
AID208222In vitro antiparasitic activity against Trypanosoma brucei was tested by sigmoidal regression analysis2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID1157239Inhibition of proto-oncogene protein Wnt in p53-deficient human HCT116 cells assessed as downregulation of beta-catenin protein expression at 10 uM after 24 hrs by Western blot analysis relative to control2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1594145Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1602997Cytotoxicity against paclitaxel-resistant human MCF7/PTX cells assessed as reduction in cell viability after 24 hrs by MTT assay2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID403275Antimicrobial activity against Mycobacterium smegmatis after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1491232Selectivity ratio of IC50 for human HepG2 cells to IC50 for human MDA-MB-231 cells2017European journal of medicinal chemistry, Sep-08, Volume: 137Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
AID629593Cytotoxicity against human PBMC cells assessed as viable fractions using annexin V-FITC/propidium iodide staining by flow cytometry2011European journal of medicinal chemistry, Dec, Volume: 46, Issue:12
Anti-tumoral activities of dioncoquinones B and C and related naphthoquinones gained from total synthesis or isolation from plants.
AID1607751Inhibition of P300 in human HeLa cells using [3H]-acetyl-CoA as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins by liquid scintillation counting analysis2019European journal of medicinal chemistry, Sep-15, Volume: 178Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism.
AID669215Induction of cell cycle arrest in Her2-overexpressing human SKBR3 cells assessed as increase in DNA accumulation at subG1 phase at 10 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis (Rvb = 11%)2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID357213Ratio of MBC to MIC for Staphylococcus aureus2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID1625336Increase in calcium level in DRG neurons isolated from TRPA1 deficient mouse at 10 uM by fura2/AM dye based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID670009Induction of apoptosis in Her2-overexpressing human BT474 cells assessed as decrease in Bcl-2 protein level after 24 hrs by Western blot analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1156520Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID1602980Induction of apoptosis in human MCF7 cells up to 3 uM after 24 hrs in presence of 1 nM of paclitaxel by Annexin V-phycoerythrin/7-AAD staining based flow cytometric analysis relative to control2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1157216Cytotoxicity against human SW480 cells assessed as cell viability after 48 hrs by MTT assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1179567Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID403272Antimicrobial activity against Micrococcus luteus assessed as 99.9 % growth inhibition after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1157230Inhibition of proto-oncogene protein Wnt in human SW480 cells assessed as downregulation of Bcl9l protein expression at 6 to 10 uM after 24 hrs by Western blot analysis2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1179571Antifungal activity against fluconazole-resistant Candida albicans at 100 ug/well after 24 hrs by well diffusion assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID1326306Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by broth microdilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID1517764Binding affinity to MKK7 (unknown origin) expressed in HEK293 cells assessed as dissociation constant by kinomescan method2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID1602974Synergistic cytotoxicity against human MDA-MB-468 cells assessed as combination index at 0.5 to 2 uM after 24 hrs in presence of 5 to 20 nM of paclitaxel by MTT assay2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID751143Antiinflammatory activity in C57-B16/J mouse chronic DSS-induced ulcerative colitis model assessed as decrease in serum IL-17 level at 10 mg/kg administered for total of 3 weeks for alternative weeks with water measured after 63 days by ELISA relative to 2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID657262Antiproliferative activity against ER-negative human MDA-MB-231 cells after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells.
AID1156522Cytotoxicity against human HT-29 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
AID751140Antiinflammatory activity in C57-B16/J mouse DSS-induced ulcerative colitis model assessed as restoration of crypts at 10 mg/kg by hematoxylin-eosin staining-based microscopic analysis2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID1271956Growth inhibition of human MCF7 cells by MTT assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID1602990Inhibition of ERK1/2 in human MDA-MB-468 cells assessed as reduction in EGF-induced phosphorylation of ERK1/2 at Thr202/Tyr204 residues up to 1 uM preincubated for 1 hrs followed by EGF addition and measured after 30 mins by AlphaScreen analysis relative 2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1326317Antimicrobial activity against vancomycin-resistant Enterococcus faecalis after 18 hrs by broth microdilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID479265Larvicidal activity against Aedes aegypti fourth instar larvae at 6.5 ug/ml after 24 hrs2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Bioactivity-guided isolation of mosquitocidal constituents from the rhizomes of Plumbago capensis Thunb.
AID1491224Cytotoxicity against human HepG2 cells assessed as growth inhibition at 10 uM after 72 hrs by MTT assay relative to control2017European journal of medicinal chemistry, Sep-08, Volume: 137Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
AID212727Inhibitory activity against Trypanosoma cruzi trypanothione disulfide reductase, assay in presence of 57 uM T(S)2.2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID1507435Antitrypanosomal activity against bloodstream forms of Trypanosoma cruzi Y isolated from parasite infected Albino Swiss mouse assessed as induction of parasite lysis incubated for 24 hrs by Neubauer chamber based cell counting method2017European journal of medicinal chemistry, Aug-18, Volume: 136Rhodium-catalyzed C-H bond activation for the synthesis of quinonoid compounds: Significant Anti-Trypanosoma cruzi activities and electrochemical studies of functionalized quinones.
AID212594The second order rate constant of the TcLipDH (Trypanosoma cruzi lipoamide dehydrogenase) catalyzed NADH oxidation. 2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID1517774Cytotoxicity against human LS174T cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent cell viability assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
AID403288Toxicity in human LU1 cell xenografted mouse assessed as body weight loss at 5 mg/kg2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1271963Cytotoxicity against human U373 cells at 5 uM after 72 hrs by video microscopic analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
AID1062008Cytotoxicity against human MCF7 cells expressing HER2delta16 assessed as reduction of cell viability after 48 hrs CellTiter-Glo assay2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
AID1157241Upregulation of HBP1 protein expression in human HCT116 cells expressing p53 at 10 uM after 24 hrs by Western blot analysis2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID103794The Michaelis-Menten constant for NADPH oxidation by pig heart LipDH (lipoamide dehydrogenase)2001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID751146Antiinflammatory activity in C57-B16/J mouse chronic DSS-induced ulcerative colitis model assessed as decrease in serum TNFalpha level at 10 mg/kg administered for total of 3 weeks for alternative weeks with water measured after 63 days by ELISA relative 2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
AID1444782Inhibition of FAK/AKT/ROCK in human A549 cells assessed as reduction in osteopontin-induced lamellipodia formation at 2 uM after 24 hrs by rhodamine phalloidin/DAPI staining based confocal microscopic analysis2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID1411730Inhibition of recombinant human CYP1A1 expressed in baker's yeast-derived microsomes (Sacchrosomes) at 10 uM using 7-ethoxyresorufin substrate by EROD assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID1625348Decrease in TRPA1 current amplitude in human TRPA1 expressed HEK293 cells at 10 uM at high voltage by whole cell patch clamp assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1326318Antimicrobial activity against vancomycin-sensitive Enterococcus faecalis after 18 hrs by broth microdilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID403278Antimicrobial activity against Mycobacterium avium assessed as 99.9 % growth inhibition after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID95926In vitro antiparasitic activity against Leishmania donovani was tested by sigmoidal regression analysis; at 3 uM value is T/1002001Journal of medicinal chemistry, Feb-15, Volume: 44, Issue:4
2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
AID1594141Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID669229Anticlonogenic activity in Her2-overexpressing human BT474 cells assessed as inhibition of colony formation after 6 hrs followed by washout measured after 16 days by crystal violet staining2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1625338Increase in calcium level in HEK293 cells at 20 uM by fura2/AM dye based single cell based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1179573Antifungal activity against fluconazole-resistant Candida albicans by NCCLS method2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID356958Antibacterial activity against Staphylococcus aureus after 24 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID1755842Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by MTT assay2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID670010Induction of apoptosis in Her2-overexpressing human SKBR3 cells assessed as increase in BaK protein level after 24 hrs by Western blot analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1444775Inhibition of FAK/AKT/ROCK in human A549 cells assessed as reduction in osteopontin-induced cell motility at 2 uM preincubated for 30 mins followed by osteopontin addition measured after 24 hrs by Diff-quick staining based matrigel-mediated Boyden chamber2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID669210Induction of apoptosis in Her2-overexpressing human SKBR3 cells assessed as increase in caspase activity after 6 hrs by fluorescence analysis relative to control2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID669230Anticlonogenic activity in Her2-overexpressing human SKBR3 cells assessed as inhibition of colony formation after 6 hrs followed by washout measured after 16 days by crystal violet staining2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1411736Inhibition of recombinant human CYP2C9 expressed in baker's yeast-derived microsomes (Sacchrosomes) at 10 uM using 3-cyano-7-ethoxycoumarin substrate by EROD assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID1091719Antifeedant activity against third-instar larvae of tobacco caterpillar Spodoptera litura in compound treated fresh castor leaves assessed as consumption at 0.1% measured after 6 to 24 hr2009Journal of agricultural and food chemistry, Jul-22, Volume: 57, Issue:14
Synthesis and insect antifeedant activity of plumbagin derivatives with the amino acid moiety.
AID1157225Inhibition of proto-oncogene protein Wnt in human SW620 cells assessed as downregulation of TCF7L2 protein expression at 6 uM after 24 hrs by Western blot analysis2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID669227Cytotoxicity against Her2-overexpressing human SKBR3 cells after 24 to 72 hrs by MTT assay2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID669213Induction of apoptosis in Her2-overexpressing human BT474 cells assessed as increase in caspase activity after 6 hrs by fluorescence analysis2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID669222Cytotoxicity against Her2-overexpressing human SKBR3 cells after 72 hrs by MTT assay2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1157231Inhibition of proto-oncogene protein Wnt/beta-catenin in human SW620 cells assessed as downregulation of c-Myc protein expression at 6 uM after 24 hrs by Western blot analysis relative to control2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID669228Cytotoxicity against Her2-overexpressing human BT474 cells after 24 to 72 hrs by MTT assay2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1157218Cytotoxicity against human SW620 cells assessed as cell viability after 48 hrs by MTT assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1282386Inhibition of full length recombinant His6-tagged p300 (unknown origin) expressed in baculovirus expression system using histone substrate after 10 mins by liquid scintillation counting method in presence of [3H]acetyl-CoA2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
AID1397257Cytotoxicity against human HL60 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Anti-acute myeloid leukemia activity of 2-chloro-3-alkyl-1,4-naphthoquinone derivatives through inducing mtDNA damage and GSH depletion.
AID1062012Cytotoxicity against human MCF7 cells expressing HER2delta16 assessed as reduction of cell viability at 10 uM after 48 hrs CellTiter-Glo assay2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
AID1444784Anti-invasive activity in human A549 cells assessed as reduction in osteopontin-induced ROCK1 expression after 24 hrs by Western blot method2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID1166625Antitubercular activity against Mycobacterium tuberculosis ATCC 27294 in low iron condition after 5 days by Alamar blue assay2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Synthesis, characterization, molecular docking and anti-tubercular activity of Plumbagin-Isoniazid Analog and its β-cyclodextrin conjugate.
AID696883Induction of eryptosis in human erythrocytes assessed as cell membrane scrambling at 1 uM after 48 hrs by annexin V staining-based FACS analysis in nominal absence of extracellular Ca2+2012Journal of natural products, Nov-26, Volume: 75, Issue:11
Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
AID1444777Inhibition of FAK/AKT/ROCK in human H1299 cells assessed as reduction in osteopontin-induced cell invasion at 1 to 2 uM preincubated for 30 mins followed by osteopontin addition measured after 24 hrs by Diff-quick staining based matrigel-mediated Boyden c2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID214491Concentration required for inhibition of Trypanothione reductase (TcTR) from Trypanosoma cruzi in the presence of 50 uM TS2 as substrate2000Bioorganic & medicinal chemistry letters, Apr-03, Volume: 10, Issue:7
Parallel synthesis of a library of 1,4-naphthoquinones and automated screening of potential inhibitors of trypanothione reductase from Trypanosoma cruzi.
AID1411742Inhibition of human recombinant CYP2D6 expressed in HEK293 cells using 7-ethoxy-methyloxy-3-cyanocoumarin substrate substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins by fluorescence assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID1326307Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC BAA-41 after 18 hrs by broth microdilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID403277Antimicrobial activity against Mycobacterium avium after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID403276Antimicrobial activity against Mycobacterium smegmatis assessed as 99.9 % growth inhibition after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID403271Antimicrobial activity against Micrococcus luteus after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1091724Antifeedant activity against third instar larvae of Achaea janata in compound treated fresh castor leaves assessed as consumption at 28 +/- 2 degC, relative humidity 65 +/- 5 measured after 6 to 24 hr2009Journal of agricultural and food chemistry, Jul-22, Volume: 57, Issue:14
Synthesis and insect antifeedant activity of plumbagin derivatives with the amino acid moiety.
AID1157236Inhibition of proto-oncogene protein Wnt/beta-catenin in human HCT116 cells expressing p53 assessed as downregulation of TCF/LEF promoter transcriptional activity at 5 to 10 uM after 24 hrs by TOPFlash/FOPFlash luciferase reporter gene assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID356964Antibacterial activity against vancomycin-resistant Enterococcus faecium F935 expressing VanA after 24 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID403280Antifungal activity against Cryptococcus neoformans after 18 hrs by zone-of-inhibition assay2004Journal of natural products, Jul, Volume: 67, Issue:7
Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia.
AID1411741Inhibition of human recombinant CYP1B1 expressed in HEK293 cells using 7-ethoxyresorufin substrate substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins by fluorescence assay relative to control2018MedChemComm, Feb-01, Volume: 9, Issue:2
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
AID1157221Inhibition of proto-oncogene protein Wnt/beta-catenin in human SW480 cells assessed as downregulation of TCF/LEF promoter transcriptional activity after 24 hrs by TOPFlash luciferase reporter gene assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1083211Bactericidal activity against Erwinia amylovora 295/93 assessed as growth inhibition in King's B full medium measured at pH 7.2 after overnight incubation by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID1444780Inhibition of FAK/AKT/ROCK in human A549 cells assessed as reduction in osteopontin-induced cell invasion at 2 uM preincubated for 30 mins followed by osteopontin addition measured after 24 hrs by Diff-quick staining based matrigel-mediated Boyden chamber2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID657258Partition coefficient, log P pf the compound2012Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells.
AID1157238Inhibition of proto-oncogene protein Wnt in human HCT116 cells expressing p53 assessed as downregulation of beta-catenin protein expression at 10 uM after 24 hrs by Western blot analysis relative to control2014Journal of natural products, May-23, Volume: 77, Issue:5
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
AID1602989Inhibition of ERK1/2 in human BT474 cells assessed as reduction in EGF-induced phosphorylation of ERK1/2 at Thr202/Tyr204 residues up to 2 uM preincubated for 1 hrs followed by EGF addition and measured after 30 mins by AlphaScreen analysis relative to co2019Journal of natural products, 04-26, Volume: 82, Issue:4
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
AID1444790Toxicity in BalB/c nude mouse assessed as change in body weight at 5 mg/kg, ip administered once daily for 8 weeks measured every week of compound dosing2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID629592Cytotoxicity against human INA-6 cells assessed as viable fractions using annexin V-FITC/propidium iodide staining by flow cytometry2011European journal of medicinal chemistry, Dec, Volume: 46, Issue:12
Anti-tumoral activities of dioncoquinones B and C and related naphthoquinones gained from total synthesis or isolation from plants.
AID1397259Selectivity index, ratio of IC50 for human WI38 cells to IC50 for HL60 cells2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Anti-acute myeloid leukemia activity of 2-chloro-3-alkyl-1,4-naphthoquinone derivatives through inducing mtDNA damage and GSH depletion.
AID1625341Activation of human TRPA1 expressed in HEK293 cells assessed as increase in calcium level at 20 uM by fura2/AM dye based single cell based plate reader analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
AID1179568Cytotoxicity against human SAS cells assessed as reduction in cell viability after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
AID1444773Cytotoxicity against human A549 cells assessed as reduction in cell viability at 2 to 8 uM after 24 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
AID669221Cytotoxicity against Her2-overexpressing human BT474 cells after 72 hrs by MTT assay2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway.
AID1346108Human E1A binding protein p300 (Non-enzymatic BRD containing proteins)2009The Journal of biological chemistry, Sep-04, Volume: 284, Issue:36
Inhibition of lysine acetyltransferase KAT3B/p300 activity by a naturally occurring hydroxynaphthoquinone, plumbagin.
AID1346093Human lysine acetyltransferase 2B (2.3.1.48 Histone acetyltransferases (HATs))2009The Journal of biological chemistry, Sep-04, Volume: 284, Issue:36
Inhibition of lysine acetyltransferase KAT3B/p300 activity by a naturally occurring hydroxynaphthoquinone, plumbagin.
AID1801570MAO Inhibition Assay from Article 10.1111/cbdd.12708: \\Evaluation of Natural and Synthetic 1,4-naphthoquinones as Inhibitors of Monoamine Oxidase.\\2016Chemical biology & drug design, May, Volume: 87, Issue:5
Evaluation of Natural and Synthetic 1,4-naphthoquinones as Inhibitors of Monoamine Oxidase.
AID1805801Various Assay from Article 10.1021/acs.jmedchem.1c00409: \\Perspectives on SARS-CoV-2 Main Protease Inhibitors.\\2021Journal of medicinal chemistry, 12-09, Volume: 64, Issue:23
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (524)

TimeframeStudies, This Drug (%)All Drugs %
pre-199024 (4.58)18.7374
1990's40 (7.63)18.2507
2000's91 (17.37)29.6817
2010's274 (52.29)24.3611
2020's95 (18.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.78 (24.57)
Research Supply Index6.29 (2.92)
Research Growth Index5.13 (4.65)
Search Engine Demand Index64.21 (26.88)
Search Engine Supply Index2.15 (0.95)

This Compound (39.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews22 (4.10%)6.00%
Case Studies1 (0.19%)4.05%
Observational0 (0.00%)0.25%
Other514 (95.72%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]